-
Promoting heart health starts in childhood.
The article discusses the struggle against heart disease in the U.S. Two published studies about the cardiovascular consequences of childhood obesity have showed that efforts toward combating the nation's heart disease epidemic should start with children. It is noted that the heart disease is the leading cause of morbidity and mortality in the country, representing 29% of all deaths. Further details about the cause of heart disease are discussed.
-
"Obesity paradox" may be due to better treatment.
The article reports on the study conducted by Christopher Cannon and colleagues in the U.S. which found that physicians treat overweight and obese patients with heart disease more aggressively than they treat others. The researchers identified the result of the study as a possible explanation for the so-called obesity paradox, which describes the apparent contradiction in overweight or obese patients exhibiting lower short-term mortality rates after developing heart disease.
-
'Musts' for e-prescribing safety, efficiency, and more.
The article provides information related to the principles of electronic prescribing (e-prescribing). It mentions that the American Pharmacists Association recommends that e-prescribing must be designed to increase efficiency, enhance patient safety and prevent diversion of prescription drugs. It notes that an e-prescribing system must eliminate transcription errors from verbal prescription orders to improve patient safety.
-
2008 APhA Distinguished Federal Pharmacist named.
The article announces that Joseph F. Gallelli has received that 2008 American Pharmaceutical Association (APhA) Distinguished Federal Pharmacist Award.
-
2009 APhA Annual Meeting &Exposition.
The article offers information on the APhA 2009 annual meeting &exposition to be held in San Antonio, Texas in April 3-6.
-
21st-century care in a 19th-century pharmacy.
The article discusses the effort of Michael Kim to make his Grubb's Pharmacy and Medical Equipment one of the most innovative pharmacies in Washington, D.C. Kim said that he wants to take his pharmacy to the next level by managing diseases as a service to patients and doctors. The pharmacy's second floor is now being renovated with a makeover plan that includes a new compounding laboratory.
-
A fight for Medicare payment.
The article elaborates the significance of the House of Representative bill 5780 (H.R. 5780) to the pharmaceutical industry in the U.S. It is introduced by Heather Wilson aimed in paying for clinical pharmacist services under Medicare Part B. It is not intended to cover a broad range of medication therapy management (MTM) services, including the services that pharmacists provide via a protocol or collaborative drug therapy management (CDTM) agreement.
-
A look inside the PSPC change package.
The article focuses on the implementation of the health program's modification of package in the U.S. According to the article, the changing of package was supported by the teams who participated the Patient Safety and Clinical Pharmacy Services Collaborative (PSPC) and the Health Resources and Services Administration (HRSA). It cites that the program's change package is composed of several best practices gathered by the PSPC.
-
A new face for CPE.
The article reports on the introduction of guidelines for continuing pharmacy education (CPE) programs. It states that the major elements of the guidelines are specific for three classes of CPE activities and differentiated programs for pharmacists and pharmacy technicians. According to Dimitra Travlos, director of Continuing Pharmacy Education Provider Accreditation, they want to improve the quality of pharmacy education and the ability of pharmacists to look at CPE differently.
-
A room of their own.
The article reports on the American Pharmacists Association's (APhA) plan to create a Federal Pharmacy Conference room at its new headquarters building in Washington D.C. It notes that the room will be used in holding meetings and ceremonies and in recognizing pharmacists who had made important contributions in the field and in the association. It states that a minimum of $100,000 is needed by APhA for the project.
-
A warning about warning labels: Impact of low literacy.
The article features the importance of prescription drug warning labels (PWL) to patients in the U.S. It is vital to patients because it informs them of the important instruction for the safe use of medications, and pharmacists rely on it to communicate important warnings to patients. Studies show that such labels can be disadvantageous to patients with low literacy. Researchers found that the rate of correct interpretation ranged from 0% to 78.7%, thus they recommend to have patient counseling.
-
ACC 57th Annual Scientific Session.
Information about several papers discussed at the American College of Cardiology 57th Annual Scientific Session from March 29 to April 1, 2008 is presented. The final results of the effect of combination ezetimibe and high-dose simvastatin versus simvastatin alone on the atherosclerotic process in patient with heterozygous familial hypercholesterolemia and the result of the ongoing telmisartan alone and combination with ramipril global endpoint trial were presented at the meeting.
-
ACPE activity types make choosing CPE easier.
The article reports on the release of the new guidelines for continuing pharmacy education (CPE) by the Accreditation Council for Pharmacy Education (ACPE) in the U.S. The new guideline allow pharmacists to customize their CPE selections based on the time available and the level of information needed. CoraLynn B. Trewet of the University of Iowa states that the new standards will guide pharmacists towards continuing professional development (CDP) when thinking about their learning.
-
Act like a manufacturer and you may be treated like one.
The article reports on the lawsuits filed against an Alabama pharmacy for allegedly shipping recalled batch of drugs. It cites that the lawsuits are brought by individuals as product liability claims and not as malpractice claims. It reveals that the pharmacy should have to fight itself as manufacturer rather than as health provider. Moreover, it is noted that the pharmacy which behaves like manufacturer would not be given the benefits of malpractice reform law.
-
Adolescent OTC labeling, ad changes possible, but years away.
The article reports on the introduction of Adolescent Over-the-Counter Drug Product Use, a 2-day public workshop for researchers in fields ranging from marketing to neural development by the National Institute of Health, Food and Drug Administration and Consumer Healthcare Products Association in the U.S. The introduced workshop is culminated in a 14-person roundtable focusing on strategies to address adolescent OTC drug use.
-
Adriamycin out, Taxotere in for early breast cancer.
Information about several topics discussed at the 30th annual San Antonio Breast Cancer Symposium (SABCS) is presented. Topics include clinical benefits of neoadjuvant therapy for invasive breast cancer. The symposium also highlights the efficacy data on docetaxel from seven-year follow-up of patients with breast cancer.
-
Advancing Your Practice.
The article offers information on the medication therapy management (MTM), a process of care that pharmacists use to address patients needs. It is noted that the American Pharmacists Association (APHA) is working with other national pharmacy organizations to support pharmacists as they establish and expand MTM. APHA in collaboration with the American Society of Consultant Pharmacists, has launched an MTM Certificate Training Program in March 2007. Benefits of MTM to patients are also cited.
-
Adverse Event Reporting--Why and How.
The article offers information about the importance of adverse event reporting on the pharmaceutical industry in the U.S. Adverse event reporting is important since the Food and Drug Administration (FDA) relies on it which helps identify potential risks of medical products following their introduction to the market. Adverse events are defined by FDA as any undesirable experience associated with the use of medical products in a patient.
-
Aggressive therapy may reduce mortality for some patients with diabetes.
The article reports on the study which shows aggressive treatment for patients with diabetes may reduce mortality. The research indicates that treatment that targets multiple risk factors may reduce the risk of death in patients with type 2 diabetes and signs of kidney damage. Intensive therapy was significantly associated with lower risk of death from any cause. Patients with diabetes who were at high risk for heart attack and stroke were more likely to die when receiving the more therapy.
-
AHA releases treatment guidelines for resistant hypertension.
The article reports on the treatment guidelines for hypertension that does not respond to traditional treatments released by the American Health Association. It relates that the guidelines recommend the consideration of lifestyle factors, diagnosis and secondary causes and effective use of medications. The guidelines specifically mention the use of diuretics and mineralocorticoid receptor antagonists, such as spironolactone as medications for patients with resistant hypertension.
-
Alcohol and OTC Analgesic Use.
The article explores the side effects of combining alcohol and over-the-counter (OTC) analgesic uses by a certain person. It cites one study which reveals that the risk of gastrointestinal (GI) bleeding increases as analgesics and alcohol were combined. Because of the combination's side effect, medical professionals are advised to counsel their patients about the risks or danger of such combination.
-
American Heart Association.
The article presents the logo of the American Heart Association in the U.S.
-
American Pharmacists Month 2008: The profession at its best.
The author reflects on the opportunities provided by the American Pharmacists Month to the pharmacies and pharmacists. He states that pharmacists are establishing broad-based and highly effective medication therapy management (MTM) services, while pharmacy is a rewarding career from both a profession and financial perspective. He believes that the present pharmacists are ready to fulfill their mission to patients and their roles as valuable members of the health care team.
-
AMERICAN PHARMACISTS MONTH.
The article reports on the program established by Michelle Herbert Thomas of Bremo Pharmacy in Richmond, Virginia and her colleagues in connection with the American Pharmacists Month. The program, dubbed as Bremo Diabetes Lifecare, provides practical guidance on diabetes basics, healthy eating habits, blood glucose monitoring, and preventing complications. Thomas suggests pharmacists to be willing and able to change level of interaction based on patient responses.
-
American Pharmacists Month: Celebrating the profession.
The article announces that the U.S. House of Representatives have designated October American Pharmacists Month with H.Res.1437. The event recognizes the contributions made by pharmacists to the health and well-being of its citizens. The aspects of medication therapy management were highlighted as part of the month's outreach activities. The first full week of the month focused on the importance of immunizations and Centers for Medicare &Medicaid Services' Get Smart About Antibiotics program.
-
Americans support pharmacy tech certification, PTCB says.
The article reports on the result of the survey conducted by the Pharmacy Technician Certification Board company (PTCB) concerning certification of pharmacy technicians in the U.S. According to the survey, more than 90% of respondents have asserted that they believe on the state regulations that required pharmacy technicians to undergo training and certification. The survey further reveals that 58% of respondents have believed that only licensed pharmacist could dispense medications.
-
Antidementia drug may help control binge eating.
The article cites a study which found new options for controlling compulsion of patients suffering from binge eating disorder. The study, conducted by Doctor Brian P. Brennan and colleagues, indicates that the Alzheimer's disease medication memantine is effective in decreasing the frequency and severity of binge eating episodes. It also found that patients treated with memantine did not experience any notable changes in body weight, depression, and anxiety during the course of the study.
-
Antiepileptic drugs linked to increased suicidality.
The article reports on the findings by the Food and Drug Administration (FDA) regarding the effects of the drugs used to treat epilepsy and psychiatric disorders in the U.S. According to the study, these types of drugs may increase the risk of suicidal behavior and ideation. It also recommends close monitoring of all patients currently taking any antiepileptic drug. The increased risk of suicide is present as early as one week after a person takes the drug and continues through 24 weeks.
-
Antipyretics and kids: Teach parents, caregivers to be SAFER!
The article discusses the implication of antipyretic medications to children with fever in the U.S. The common medication for fever are acetaminophen and ibuprofen, but if not correctly administered, they can have serious adverse consequences. Experts suggested that when recommending antipyretics, parents and caregivers should speak up, ask questions, find the facts, evaluate choices, and read the label. Presented are tips on how to effectively evaluate children with fevers.
-
APhA Academy awardees to be recognized at APhA2008.
The article announces awards given to pharmacists including Distinguished Achievement Award in Administrative Practice to Thomas P. Reinders, Distinguished Achievement Award in Hospital and Institutional Practice to Lisa Hutchison and Distinguished Achievement Award in Specialized Pharmacy Practice to David H. Schwed.
-
APhA Advocacy: Strengthening Your Profession.
The article focuses on the patient advocacy of the American Pharmacists Association (APHA) to state, national and international negotiation concerning pharmacy. APHA Academies provided information about medication therapy management, mandatory electronic prescribing and behind-the-counter drugs. It is noted that APHA is also active with federal regulatory agencies such as the U.S. Food and Drug Administration and Centers for Medicare and Medicaid Services.
-
APhA and Medication Therapy Management.
The article offers information on the medication therapy management (MTM), a process of care that pharmacists use to address patients needs. It is noted that the American Pharmacists Association (APHA) is working with other national pharmacy organizations to support pharmacists as they establish and expand MTM. APHA in collaboration with the American Society of Consultant Pharmacists, has launched an MTM Certificate Training Program in March 2007. Benefits of MTM to patients are also cited.
-
APhA in 2007: Generating Pride in Our Profession, Ourselves.
The author recounts the accomplishments of the American Pharmacists Association in 2007. He claims that the association has established and maintained privileges, which society extends to pharmacists in return for their professional services. He adds that the association has developed a set of tools, which pharmacists can use in daily practice. He asserts that the association will continue to work with members and develop solutions to help patients live longer.
-
APhA joins Illinois Pharmacists Association to support right of conscience.
The article reports that the American Pharmacists Association and the Illinois Pharmacists Association support the pharmacists' rights of conscience in the case of Morr-Fitz v. Blagojevich. It mentions that in the case, the plaintiffs have asked for the rule requiring pharmacists to dispense emergency contraception despite moral objections to be null, arguing that it violates the First Amendment, the Illinois Health Care Right of Conscience Act and the Illinois Religious Freedom Restoration Act.
-
APhA Membership: Stimulating Your Career.
The article focuses on the significance of the American Pharmacists Association (APHA) membership. It has been claimed that the organization is there with education, information and advocacy, that would ensure a lifelong relationship with member-pharmacists. APHA provides pharmacists with medication therapy management tools and resources. It is also noted that more pharmacists are entering Community Pharmacy Residency Programs in which APHA has been helpful in the growth of the movement.
-
APhA named to Scientific American 50.
The article announces the inclusion of American Pharmaceutical Association (APhA) in the sixth annual Scientific American 50 award. It is stated that APha as well as U.S. Fish and Wildlife Service have received a joint recognition as policy leaders for fighting toxins in the home. Moreover, it is noted that fellow honorees of APha includes Apple Inc. and Google Inc.
-
APhA names Thomas Menighan Executive VP and CEO.
The article announces that Thomas E. Menighan was promoted chief executive officer (CEO) and executive vice president of the American Public Health Association (APhA).
-
APhA participates in FDA meeting on influenza MedKit.
Information about the topics discussed at the Food and Drug Administration (FDA) meeting led by its Antiviral Drugs Advisory Committees is presented. Topics include the types of studies and trial designs which are needed for the influenza antiviral medical kit and a proposal for the development of influenza medical kit program. The meeting was participated by the American Public Health Association (APhA).
-
APhA working for you.
The article offers news briefs related to pharmaceutical services in the U.S. The Board of Pharmaceutical Specialties (BPS) has announced the results of its record-breaking 2007 exam cycle. The Health Resources and Services Administration has extended Pharmacy Services Support Center's (PSSC) contract with the American Pharmacists Association (APhA) for another 5 years.
-
APhA working for you.
The author presents the proposed policy statements of the American Pharmaceutical Association (APhA) which were discussed at the APhA 2008 annual meeting in San Diego, California. APhA urges state boards of pharmacy, professional associations, and other stakeholders to refine in the development of blueprint that evaluates experiential education requirements. It supports compounding as defined by the Pharmacy Compounding Accreditation Board (PCAB) as a means to meet patient drug therapy needs.
-
APhA working for you.
The article offers news briefs related to the American Pharmaceutical Association (APhA). The Alliance for Pharmaceutical Care showed state legislators the value of medication therapy management (MTM) during the National Conference of State Legislatures in New Orleans. The Institute of Medicine reports encouraged collaboration among educators and health professionals from various medical disciplines.
-
APhA working for you.
The article provides updates related to American Public Health Association (APhA) in the U.S. APhA will be introducing its Health-System Edition of the "Pharmacy Today" journal in January 2009. The new educational web site of Pfizer Inc., titled "Medicine Safety Education" was evaluated by APhA. The MTM CE Monograph Series of the APhA will be providing a complete MTM educational programs for pharmacists and student pharmacists in the country.
-
APhA working for you.
The article reports on the developments at the American Pharmaceutical Association (APhA) in the U.S. The webpage of the APhA Academy of Student Pharmacists (APhA-ASP) has been revamped wherein extra content was added to prepare student pharmacists for election day. The APhA Foundation and Mirixa Corp. have announced a partnership that will allow a broader platform for delivering pharmacist-focused patient care services.
-
APhA working for you.
The article offers information about several policies adopted by the American Pharmacists Association (APhA) House of Delegates at the APhA2008 in San Diego, California. These policies which are announced as the association's official policies, include experiential education, residency training for pharmacists, and pharmacy compounding accreditation. The association also adopted the policies on pharmacy technician education and training.
-
APhA working for you.
Information about several papers discussed at the 2008 American Public Health Association (APhA) Academies Leadership Meeting (ALM) held in Bethesda, Maryland on April 25-27, 2008 is presented. John A. Gans, executive vice president and chief executive officer (CEO), described how the U.S. lagged behind other countries in terms of health care quality, ranking 37th, but leading the way in health care spending.
-
APhA working for you.
The article focuses on the efforts by the staff members of the American Pharmaceutical Association (APhA) to culminate programs for the pharmacists' medication therapy management (MTM) service activities in the U.S. The feature of this activity is the release of Medication Therapy Management in Pharmacy Practice: Core Elements of an MTM Service Version 2.0. This document includes five core elements of an MTM service review. It also focused on the increasing emphasis on health care transitions.
-
APhA working for you.
The article reports on the services offered by the American Pharmaceutical Association (AphA) in the U.S. The association helps to educate patients, pharmacists, and prescribers on implementing the second phase of the Medicaid tamper-resistant prescription requirement. It also partnered with the National Association of Chain Drug Stores (NACDS) Foundation to introduce a practical and informative webinar addressing the development medication therapy management core elements model.
-
APhA working for you.
2008 ELECTION
-
APhA-APPM contributed papers honored.
Information about several papers discussed at the 2008 APhA Contributed Papers Poster Session held in San Diego, California on March 14-17, 2008 is presented. The event provides practitioners, scientists and student pharmacists with an opportunities to share innovative practice information, disseminate research findings, and share educational tools.
-
APhA-ASP honorees support, inspire students.
The article reports that American Pharmacists Association Academy of Student Pharmacist (APhA-ASP) has recognized outstanding achievements and contributions in pharmacy education and professional development during the 2008 APhA Annual Meeting and Exposition st the San Diego Convention Center in San Diego, California on March 17, 2008. It presents several professional awardees and illustrates the awardees' contributions and achievements in their fields.
-
APhA2008: Our ticket to a brighter pharmacy future.
The author reflects on the APhA 2008, the American Pharmaceutical Association's Annual Meeting &Exposition to be held from March 14-17, 2008 in San Diego, California. He says that the event will provide a beautiful setting for pharmacists to focus on creating brighter future. He adds that the meeting will tackle some important issues in creating a stronger profession. He also suggests that pharmacists should know about the best evidence in preventing and treating diseases.
-
APhA2008: Stamping your ticket to a bright future.
Information about the 156th annual meeting and exposition of the American Pharmacists Association held in San Diego, California, from March 14-17, 2008 is presented. The meeting was attended by 6,900 participants, including pharmacists from all practice settings, students, technicians and industry representatives. Highlighted at the event was the pharmacy profession's advocacy, growth and success.
-
APhA: Bringing Your Medicines to Life.
The article focuses on the Bringing Your Medicines to Life, a campaign by the American Pharmacists Association (APHA). The effort is geared to renovate and expand the association's historic national landmark headquarters building. The campaign, which has been announced at the APHA2007 Annual Meeting and Exposition has given attendees the chance to support it through the purchase of granite pavers.
-
APhA: Connecting With Your Community.
The article focuses on the efforts of the American Pharmacists Association (APHA) to ensure care for all patients in communities in the country. APHA manages the Pharmacy Services Support Center, which assists the Health Resources and Services Administration to provide cost effective pharmacy services. Furthermore, the association has collaborated with other organizations on patient safety issues.
-
APhA: Your Professional Association.
The article presents the American Pharmacists Association's leaders which include Winnie A. Landis, president, Timothy L. Tucker, president-elect and Gary W. Kadlec, treasurer.
-
Appleby moves to gerontological society.
The article announces that James C. Appleby has been appointed as executive director of the Gerontological Society of America.
-
Appropriate Use of Common OTC Analgesics and Cough and Cold Medications.
The article offers information about the monograph "Appropriate Use of Common OTC Analgesics and Cough and Cold Medications." The said monologue was prepared by Sarah Smiley Young. Its reporters include University of Pittsburg Medical Center Shadyside Family Practice Residency Program former director David A. Blandino, Elaine L. Reed of the University of Illinois at Urbana, and family physician Kathleen Romito who is based in Boise, Idaho.
-
Are You Healing Your Patient's Cold Sore -- Or Just Soothing It?
The article offers information on how to treat a cold sore. It is stated that outbreaks of recurrent cold sore have impacted about 20% to 40% of adults. Since there is no cure for cold sore, it is noted that the primary goal of therapy is to shorten the healing process, shorten the symptom duration and lessen the discomfort. Moreover, it cites that various cold sore outbreaks are treated with non-prescription products.
-
Are you ready for APhM?
The article reports on the preparations undertaken by the pharmaceutical industry to prepare for the commemoration of the American Pharmacists Month (APhM) to be held in Lewiston, Maine on July 1, 2008. Due to the success of the previous APhM events, the industry made the necessary preparations. On January 18, 2008, the APhM planning begins when APhM Panel of Advisors met at APhA headquarter in Washington D.C. Discussed are the details of the preparations.
-
Are you recommending the right stuff?
The article offers information with regards to the treatment of common cough and colds. The American College of Chest Physicians (ACCP) recommend a first-generation anti-histamine (bromphedrine) and pseudoephedrine in reducing cough associated with the common cold. A randomized, placebo-controlled study of cough and the common cold demonstrated that cough improved currently with decreases in throat clearing and postnasal drip in patients treated with brompheniramine and pseudoephedrine.
-
Asheville Project, Diabetes Ten City Challenge report successes.
The article offers information on Asheville Project and Diabetes Ten City Challenge (DTCC), the two major health programs that respond to health problems in the U.S. It cites that both health projects have offered evidence that pharmacists have unprecedented opportunity to help the patients on their medication management and overall wellness. Moreover, it is noted that both health programs have highlighted the important role of pharmacists by providing patient education and monitoring efficacy.
-
Assessing patients' understanding and concerns.
The article focuses on a successful patient counseling by a pharmacist. It mentions that successful counseling sessions involve assessing patient's understanding of the reason for therapy and addressing current or anticipated problems of importance to the patient. The author notes that if a pharmacist already understands the patient's worries, the counseling session can be adapted to address the concerns, reduce anxiety and promote adherence.
-
Association awards to be conferred at APhA2008.
The article highlights the 2008 American Pharmacists Association awardees in the pharmacy profession in the U.S. It presents the names of professional pharmacists and a student pharmacist to be given corresponding awards. It also introduces the 2008 honorees in the public health and pharmacy profession.
-
AstraZeneca submits Symbicort for COPD indication.
The article elaborates the submission of a supplemental new drug application for Symbicort by AstraZeneca in the U.S. It was submitted to the Food and Drug Administration as a treatment for chronic obstructive pulmonary disease (COPD). At present, the drug was used as a treatment of asthma but the company found that it was also effective in treating moderate to severe COPD.
-
At a glance.
The article takes a look on the study of inherited variation in drug-metabolizing enzymes and drug responses. It is stated that the study exists for pharmacists in wide areas including developing research methodologies, establishing the value of pharmacogenetic testing, and participating the education and infrastructure development that fosters implementation of pharmacogenetic technologies. Further, it reveals that pharmacists will need to assess patient genetic information to ensure treatment.
-
Ayurvedic medications: Beware online products.
The article provides information on Ayurvedic medicine. This medicine is a holistic practice that aims to integrate and balance the mind, body, and spirit to prevent illness and promote happiness and health. The use of herbs is a cornerstone of this therapy, with more than 600 herbal formulas used in Ayurvedic practice. Moreover, some Ayurvedic formulas include a mixture of plants and metals prepared in a practice called rasa shastra.
-
Balancing act: A changing pharmacy workforce.
The author reflects on the changing workforce in the pharmaceutical industry. He refers to the four generations working together in the employment in the industry. He argues that the Millenial generation will be interesting additions to the pharmacy as they take on pharmacist, student, and technician roles. He concludes that a change in pharmacist professional practice will be inevitable and necessitate a careful reexamination of the pharmacy workplace.
-
Beyond medication therapy management.
The article focuses on the Project Destiny initiative of the American Pharmacists Association, the National Association of Chain Drug Stores and the National Community Pharmacists Association. It mentions that the goal of the initiative is to develop a replicable, scalable, measurable and economically viable future model for community pharmacy. It notes that the project has identified a journey map for community pharmacy focused on the health care business and value of pharmacists' services.
-
Big month, big shoes.
The author reflects on the opportunity provided by the American Pharmacists Month for pharmacists, pharmacy technicians, and student pharmacists to reflect their professional accomplishment. He cites the vision of American Pharmaceutical Association Chief Executive Officer John A. Gans that led to the development of networks and partnerships to advance pharmacy's mission. He suggests the need for executives to enable those with specialized knowledge to grow, mature, and succeed.
-
Brain power: Update from AAN 2008.
Information about several papers discussed at the American Academy of Neurology (AAN) held in Chicago, Illinois on April 12-19, 2008. It attracted more than 10,000 neurologists and neuroscientists for an exchange of the latest information and research findings. Jack Tsao and colleagues presented the results of their research on the impact of lifestyle choices on neurologic diseases, the effects of various drug therapies on cognition and promising therapies for Alzheimers and multiple sclerosis.
-
Bringing MTM to transplant patients.
The article profiles Tracy Anderson-Haag, clinical pharmacists at Hennepin Country Medical Center in Minneapolis. She develops a practice in the center's ambulatory transplant clinic along with the inpatient surgery transplant service. She aims to work the ambulatory clinic into a fully operational medication therapy management service, complete with billing. She also worked with the patient's pharmacy to switch the patient off all medication containing the blue dye.
-
Bringing student pharmacists into the patient care process.
The article discusses the significance of experiential learning to student pharmacists in the U.S. Such kind of experience is important to the profession because it provides medication therapy management (MTM). To further their knowledge on the importance of patient care, the industry provides a series of workshops and training exercises. Discussed are the details of the issue.
-
Brochure helps pharmacists target eye allergies.
The article reports on the free educational brochure released by the Asthma and Allergy Foundation of America (AAFA) entitled "Eye Health and Allergies." The brochure contains basic information about the symptoms affecting the eyes, as well as treatments for the condition and advices for patients wearing contact lenses. The brochure can be downloaded in PDF format at www.aafa.org and can be ordered through contacting eyeallergybrochure@rprny.org.
-
BTC medications: Building on pharmacy's immunization track record.
The author reflects on the importance of permitting the administration of vaccine services by pharmacists in the U.S. He said that the permission is important in many ways since it allows tract record of immunizations that offer a behind-the-counter (BTC) category of medication and the recognition of pharmacists as partners in the public health community. He suggests that one important aspect of the pharmacists' goal is to improve the medication use and advance patient care.
-
Building a greener future.
The article reports that the American Pharmacists Association (APhA) has sought to achieve the silver status certification from the U.S. Green Building Council's Leadership in Energy and Environmental Design (LEED) Green Building Rating System. APhA must comply with LEED's criteria in order to achieve the silver level certification. Furthermore, APhA also planned to implement a Green House-keeping Program once the new building is fully operational.
-
California extends pedigree and serialization deadline.
The article reports on the extension given by the California Board of Pharmacy to drug products' pedigree, serialization and interoperability deadline which was set for January 1, 2009. The new deadline is now set for January 1, 2011. It notes that the rule will require that all drugs purchased by pharmacies and sold by wholesalers should include on the packaging a unique serial number and complete electronic pedigree.
-
California pharmacist and APhA Trustee provides medical care to U.S. Olympic team.
The article reports on the works of Michael A. Pavlovich, head pharmacist for HNP Pharmaceuticals company of Torrance, as a designated pharmacist on the medical staff of the 2008 U.S. Olympic team. It states that he was responsible for providing all of American athletes with the prescription and nonprescription drugs they needed. HNP Pharmaceuticals is a compounding laboratory providing compounding drugs to many professional and collegiate sports teams.
-
Canadian pharmacist offers model of counseling.
A personal narrative is presented which explores the author's experience about the couselling offered by Canadian pharmacist to him.
-
Caring for patients with celiac disease: The role of the pharmacist.
Objective: To review the epidemiology, pathophysiology, diagnosis, treatment, and complications of celiac disease, in order to provide guidance to pharmacists. Data sources: Published articles identified through Medline using search terms such as celiac disease, gluten sensitivity, and gluten enteropathy. Additional resources were identified from personal bibliographies collected by the authors and bibliographies from gathered articles. Data synthesis: Celiac disease is an autoimmune disorder that is characterized by intolerance to gluten and affects approximately 3 million Americans. Although the most common manifestations of the disease are gastrointestinal, including diarrhea, steatorrhea, and weight loss, the disease is a multisystem disorder. Malabsorption is common, often leading to vitamin and mineral deficiencies and resulting in anemia and osteoporosis. Diagnosis is initiated through serology testing and confirmed by intestinal biopsy. The only treatment for celiac disease is strict, lifelong adherence to a gluten-free diet, which includes avoidance of foods, prescription and nonprescription pharmaceutical products, and cosmetics containing wheat, barley, and rye. Adherence to the gluten-free diet will promote intestinal healing and symptom relief and usually prevent complications of celiac disease. Conclusion: Pharmacists can play an important role by identifying patients who may have celiac disease, providing information for gluten-free foods and pharmaceutical products, and encouraging adherence to the gluten-free diet.ABSTRACT FROM AUTHORCopyright of Pharmacy Today is the property of American Pharmacists Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.
-
Caution regarding color-coded eye meds.
The article focuses on the issue concerning the color-coded eye medications and other ophthalmic products in the U.S. According to the article, it has been considered a problem for both pharmacists and nurses in dealing with the color-coded. Meanwhile, the American Academy of Ophthalmology (AAO) has made a color-coding endorsement scheme in 1996 and it was approved by the U.S. Food and Drug Administration (FDA).
-
CDC reports 'good news' for teenage immunization.
The article provides information on the annual report of the Centers for Disease Control (CDC) and Prevention in the U.S. According to the report, the national immunization trends for preteen and teenage patients indicate increasing vaccination rates, but improvement is still needed to reach the goals established in Healthy People 2010. The report reveals that the highest rates of vaccine coverage are for hepatitis B and measles-mumps-rubella, each over 80%, and for varicella at 75.7%.
-
CDC responds to reports of autism-vaccine link in children.
The article reports on the failure of scientific evidence to support any link between immunizations and mitochondrial damage that might lead to autism-like symptoms in the U.S. According to the Center for Disease Control and Prevention (CDC), revision of new immunization recommendations for children is not warranted. Julie Gerberding, director at CDC said that some of the information which is promulgated about the situation is not accurate.
-
Certifying pharmacy technicians: Is nationwide change imminent?
The article reports on the congressional bill H. R. 5491 known as Emily's Act which aims to solve the problems concerning the medical errors committed by some pharmacists in the U.S. If passed, the bill which was introduced in February 2008 would require pharmacy technicians to be registered with the board of pharmacy, have a secondary school diploma, and to be certified by the Pharmacy Technician Certification Board (PTCB).
-
Certolizumab pegol: Pegylated TNF-alpha blocker for Crohn's disease.
The article reports on the approval of the first and only pegylated tumor necrosis factor (TNF)-alpha blocker in the U.S. The medication was approved in April 2008. It is used in the treatment of Crohn's disease and for maintaining clinical response in adult patients with moderate to severe active disease who have an inadequate response to conventional therapy. Studies show that Crohn's disease is a chronic inflammatory bowel disease that affect more than one million patients worldwide.
-
Changing times.
The article discusses various reports published within the issue, including one on the impact of maldistribution of health professionals and another by David Brushwood on how the courts view pharmacists.
-
Chronic Gl inflammation raises cancer risk.
The article discusses a study on chronic gastrointestinal inflammation that increases cancer risk in the U.S. It found that chronic diseases that cause inflammation of the intestines or stomach, like ulcerative colitis or Crohn's disease may increase patients' predisposition for cancer. Researchers confirmed the link between DNA-damaging inflammation and cancer risk. The study also revealed that inflammation caused by Heliobacter pylori and hepatitis C produces cytokines, leading to cancer.
-
Clinical nuggets from APhA 2008.
Information about several papers discussed at the American Public Health Association (APhA) 2008 in San Diego, California. During the event, key educational programs on HIV research, cardiovascular self-cure, and biologics were given to attendees. Such sessions were designed to give participants the most up-to-date information about emerging research, novel drug therapies and clinical pearls for patient care.
-
Cognitive dysfunction more common in heart failure patients.
The article reports on the research published by Raymond Vogels and colleagues in the U.S. in the November 2007 issue of "Journal of the American Geriatrics Society," which found that individuals with congestive heart failure exhibited a pattern of impairment in cognitive functions. The research has indicated that the impairment was most prominent in executive function, memory, language, and mental speed.
-
Coming soon: New tools from the Pharmacy Services Support Center.
The article reports on the effort of the Pharmacy Services Support Center (PSSC) to find ways to reach people with information about the 340B discount drug pricing program in the U.S. As part of its effort, PCCS is debuting a new series of animated and narrated PowerPoint presentation designed to deliver information in an easy-to-understand format. Another tool is the Knowledge Management System which allows the public to search PCCS and the American Pharmacists Association (APhA) about 340B.
-
Common OTC Products: Are They Effective?
The article provides a review of what are considered as the most common used over-the-counter (OTC) drugs. Analgesics are suggested for recommendation provided the type of pain, the drugs' contradiction and the drugs' side effects are considered. Antihistamines cannot allegedly alleviate nasal congestion, sneezing or rhinorrhea. Decongestants are found to be effective in improving nasal airway blockage and subjective scores in adults.
-
Complementary and Alternative Medicine.
The article focuses on the complementary and alternative medicine therapies which are likewise often considered by patients. Pharmacists and physicians are advised to ask their patients or clients if they are using such therapies in order for them to provide guidance about their use. It is claimed that such therapies are excluded from the scope of the monograph "Appropriate Use of Common OTC Analgesics and Cough and Cold Medications" since they do not have any adverse effect on the patient.
-
Compounding controversy continues.
The article reports on the regulatory activity around pharmacy compounding in the U.S. The Food and Drug Administration (FDA) has sent warning letters to compounding pharmacies, asserted that they had violated federal law by making false claims on the safety and efficacy of bioidentical hormone replacement therapy (BHRT) drugs. In response, the American Pharmacists Association (AphA) requires that products compounded with estriol require an approved investigational new drug (IND) application.
-
Consultant pharmacist's responsibility is to facility, not to residents.
The article elaborates the lawsuit filed against consultant pharmacists for negligence in the U.S. It arise when a resident of a long-term care facility died, thus her estate filed a case against the company that provided the pharmaceutical services. It was alleged that the company violated its duty of reasonable care that resulted to the death of the patient. The case was dismissed on the differing perspectives of judges stressing that the role of consultant pharmacists changes.
-
Core Elements of an MTM Service Model Version 2.0 coming next month.
The article announces the release of Version 2.0 of "Medication Therapy Management (MTM) in Pharmacy Practice: Core Elements of an MTM Service Model" by the American Pharmaceutical Association (APhA) and National Association of Chain Drug Stores (NACDS) Foundation. The features of the released Version 2.0 has focused on pharmacy practice and emphasis on patient empowerment. Moreover, it is noted that the Core Element Version 2.0 has been made with input from advisory panels.
-
CORRECTION.
A correction to the article "Let's shed the sidekick role" that was published in the January 2008 issue is presented.
-
CORRECTION.
A correction to the article "Role of calcium channel blockers in treatment of hypertension" that was published in April 2008 issue is presented.
-
Counseling: A key component of patient care.
The article offers tips on patient counseling.
-
DEA proposes rules for electronic prescribing of controlled substances.
The article reports on the proposed rules by the U.S. Drug Enforcement Administration (DEA) on electronic prescriptions for controlled substances. It states that the set of rules will include specific requirements for prescribers and pharmacies as well as for the electronic service providers that will manage transactions. Pharmacies will be required to provide a digital signature certifying that the prescription was received and confirming the validity of a prescriber's DEA registration.
-
Depression more prevalent in older women.
The article reports on the medical research conducted by Lisa C. Berry which shows older women are suffering disproportionately from depression when compared with older men in the U.S. The study included 754 patients over age of 70 and were examined at 18-months intervals and continuing for 72 months. At each interval, women were significantly more likely to suffer from depression. Women were also more likely to become depressed and less likely to recover from depression.
-
Diabetes pharmacists join the blogosphere.
The article reports that Focus Express Mail Pharmacy has announced the launching of its Diabetes Pharmacist Blog in Horsham, Pennsylvania. This program will be offering information and education on diabetes, chronic illness and other related subjects. It is a free online resource that brings current articles, tips and disease management information to people with such diseases. The blog is led by Joel Shpigel, chief executive officer (CEO) at Focus Express.
-
Discipline for TPN error.
The article reports on the malpractice case filed against three pharmacists and a hospital pharmacy for a total parenteral nutrition (TPN) error that resulted to infantile fatality. The physician of the infant ordered TPN with a zinc concentration of 330 microgram (mcg) per 100 milliliter. However, the order pharmacist inadvertently selected "mg" rather than the "mcg" quantity. Unnoticed by other pharmacists, the erroneously-made TPN was administered to the baby resulting to zinc intoxication.
-
Distractions, diversions: Coupon programs are problems.
The article discusses various reports published within the issue, including one on the pharmacy chains that are moving into provision of medication therapy management and another on the problems of coupon and discount programs that lure patients from one pharmacy to another.
-
Distribution of 40-mg methadone voluntarily limited to addiction facilities, hospitals.
The article reports on the agreement reached by the pharmaceutical manufacturers, with the U.S. Drug Enforcement Administration, to voluntarily restrict distribution of methadone hydrochloride tablets 40 mg, which are dispersible, to only hospitals and facilities authorized for the treatment of opioid addiction. The restriction agreement, which will take effect on January 1, 2008, was triggered by recent increases in methadone-related adverse events, cardiotoxicity, and deaths.
-
Do you ever feel like you're playing '20 Questions'?
The article discusses the significance of an open-ended questioning process in empowering patients and pharmacists to gather complex patient care information in the U.S. An open-ended question requires more than one-word answers, which usually begin with words such as how, what and why. This type of communication allows patients to share more information using their own words. It is also essential to employ probing technique during the conversation in helping patients to express more clearly.
-
Does melatonin improve sleep in children?
The article discusses the essential factors of melatonin in improving sleeping behavior among children in the U.S. It has been said that poor sleep patterns in children may lead to a diagnosis of attention deficit/hyperactivity disorder (ADHD). Medical researchers suggest that melatonin preparation is considered an alternative to prescription and nonprescription sleep aids. Melatonin has been used in normally developing children and those with neurodevelopmental disorders with delayed sleep.
-
Don't hide the acetaminophen.
The article reports on the problems over the acetaminophen drug, the most widely used and safest analgesic. The factor that contributes to the problems involve the prescription container labeling of combination acetaminophen medications. Moreover, it offers tips for pharmacists when a patient purchase over-the-counter (OTC) acetaminophen products, such as asking patients about prescription and OTC medications and standardizing the appearance of acetaminophen on pharmacy-generated labels.
-
Drug and citrus interactions: Generalizations not enough.
The article offers information related to the adverse effects of fruit juices specifically grapefruit juice and how it affects the efficacy of medications. Evidently, irreversible inhibition of the cytochrome P450 (CYP) 3A4 isoenzyme increases drug toxicity and the organic anion transporting polypeptide (OATP) is believed to reduce drug absorving factor. Pharmacists were adviced to inform patients regarding the importance of food-drug interaction.
-
Drug suffix reforms recommended by industry representatives.
The article reports on the call of the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) for drug suffix reforms in the U.S. At a conference, NCC MERP urged the pharmaceutical industry to take steps to reduce potential errors associated with drug name suffixes. NCC MERP suggests that the industry should joint with regulatory agencies, standard-setting organizations, and practitioners.
-
DVT: No age limits for risk.
The article focuses on the Coalition to Prevent Deep-Vein Thrombosis (DVT), which aims to prevent DVT through awareness and education of patient and health professionals in the U.S. It was founded in 2003 and composed of 42 medical organizations. Activities included a public service announcement campaign using the stories of DVT patients. In the four years of its existence, the coalition has already made a great progress in patient education.
-
E-prescribing and health IT.
The article provides information on the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) in the U.S. This provision includes incentives for prescribers to implement e-prescribing in their practice settings. Moreover, the MIPPA e-prescribing provision focused even more attention on health information technology (HIT) and the need for interoperability of systems and access/input into electronic health records (EHRs).
-
Earlier pertussis vaccinations may reduce incidence, deaths.
The article presents a research conducted by Myrick C. Shinall and colleagues concerning the effectiveness of earlier pertussis vaccinations to children in the U.S. Research shows that two weeks earlier vaccination could hamper 898 hospitalization, 1,236 cases, and seven deaths of children due to pertussis. Inasmuch, it is suggested that infants must be vaccinated as early as six weeks after birth rather than to be vaccinated when they reach two months old.
-
Elderberry extract for influenza.
The article provides information on the effectiveness of elderberry extract as treatment for influenza. According to the article, elderberry has the scientific name of Sambucus nigra and cites that it has the antiviral properties that are considered effective for the mitigation of influenza viruses. In addition, elderberry has been used in ancient Greek and Egyptians in flu, cold, and sinusitis medications.
-
Elderly cardiac deaths reduced with combination treatment for high BP.
The article reports on a study about combination treatment of high blood pressure in elderly patients. The study reveals that combination treatment with a thiazide diuretic such as hydrochlorothiazide and an epithelial sodium channel (ENaC) inhibitor produced significant reductions in both coronary mortality and sudden cardiac death. The study also found significant odds ratios of 0.59 for coronary mortality and 0.60 for sudden cardiac death in patients receiving combination treatment.
-
Eliminating errors: Patient Safety and Clinical Pharmacy Services Collaborative.
The article reports on the significance of Patient Safety and Clinical Pharmacy Collaborative in the U.S. It is stated that through Patient Safety and Clinical Pharmacy Collaborative, Health Resources and Services Administration (HRSA) has worked to enhance the quality of patient-centered care by preventing medication errors. Moreover, it is noted that Patient Safety and Clinical Pharmacy Collaborative has planned to enhance the quality of patient safety and health care.
-
Enrollment in Medicare drug benefit grows 6.2%; cost projections reduced.
The article reports on the increase in Medicare prescription benefit in the U.S. The Centers for Medicare and Medicaid Services (CMS) has reported that 90% of the 44.2 million Medicare beneficiaries now have prescription drug coverage. Enrollment in various prescription drug plans (PDP) stands at 17.4 million, while eight million beneficiaries belong to Medicare Advantage. CMS Administrator Kerry Weems announced that cost projections for the benefit may decrease from the 2007 estimates.
-
EPA calls for asthma award entries.
The article reports on the call of the U.S. Environmental Protection Agency (EPA) for submission of applications for the third annual National Environmental Leadership Award in Asthma Management in the U. S. The award is introduced to health care plans and health providers with exemplary asthma management programs that have shown exceptional leadership in helping people with asthma lead healthy, active lives through the management of environmental asthma triggers.
-
EPA rule to address drugs in water.
The article reports on the proposed rule by the U.S. Environmental Protection Agency (EPA) to increase pharmaceutical collection programs and reduce drug pollution of water resources. Under the rule, EPA will list pharmaceuticals as universal waste to promote the establishment of medication disposal programs. In addition, the agency proposes future studies to evaluate health care institution disposal practices and determine pharmaceutical concentration in water resources.
-
Ergogenic supplement use.
The article reports on the issue about the increasing use of performance-enhancing supplements in the U.S. According to the author, the Food and Drug Administration (FDA) is prohibited from removing such supplements in the market unless the agency can prove that the product's agent is causing harm. It is suggested that before using such products, patients should check if its legal and discuss the facts about the products with a health professional.
-
Errors support discharge of hospital pharmacist.
The article focuses on the issue concerning racial discrimination in hiring pharmacists. According to the article, race discrimination in hiring an employee is highly forbidden in the federal Civil Rights Act. It also cites how it was promoted by the Federal Law in the country. In addition, it features the analysis rendered by the District Court in Ohio concerning the discharge of a certain Black American pharmacist.
-
Ethics and patient privacy.
Objective: To provide a brief introduction to the ethical and, to some extent, the legal issues surrounding patient privacy and confidentiality. Data synthesis: The privacy of patient medical records and patient confidentiality has moved to the forefront of ethical and legal issues in health care. Technological advances, the growth and expansion of managed care, the emergence of consumerism, and the dramatic increase in the number of individuals and organizations with access to or a need to access patient medical information have all contributed to patient concerns about who has access to their records and for what purposes. Conclusion: Questions of patient privacy and confidentiality are likely to remain at the forefront of health care ethics and law in the coming years. Health professionals, including pharmacists, have a greater responsibility than ever before to ensure that safeguards exist to prevent inappropriate access to patient information.ABSTRACT FROM AUTHORCopyright of Pharmacy Today is the property of American Pharmacists Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.
-
Etravirine: An NNRTI for resistant HIV-1 infection.
The article focuses on the etravirine tablets, the first non-nucleoside reverse transcriptase inhibitor (NNRTI) used in treating patients with HIV-resistant to an NNRTI in the U.S. The approval of etravirine by the Food and Drug Administration (FDA) offers an additional choice for treatment-experienced patients with NNRTI-resistant HIV. The approval was based on results from two 24-week observation that assessed the efficacy and safety of etravirine in such therapy.
-
Evidence-based DVT guidelines produce real-world success.
The article reports on the Call to Action issued by Acting Surgeon General Stephen K. Galson to reduce the frequency of deep-vein thrombosis (DVT) and pulmonary embolism in the U.S. In response, Chief Medical Officer Steven Berkowitz conducted a retrospective study involving a 5-year audit of the community hospital network's DVT prophylaxis plan. The study indicates that standard education measures using evidence-based guidelines significantly reduce DVT incidence.
-
Expanded tech role frees pharmacists for patient care.
The article explores the implemented pilot program at a hospital in North Carolina that enhances the role of pharmacy technicians to take part in patient care activities. The program was established in order to expand the functions of pharmacists aside from their original job responsibilities wherein they are free to practice clinical roles in patient care. Moreso, the Pharmacy Technician Principal work validation program checks the ability of the technician to prepare intravenous admixtures.
-
Expert witnesses must establish standard of care.
The article discusses the importance of the established standard of care as bases of measuring the liability of the defendants action when filing a case against a pharmacy and pharmacist's act of negligence. Negligence cases filed against pharmacists by patients need substantial support from expert witnesses to provide the jury information on how to evaluate the defendant's action against the given standards. Standard of care serves as a gauge on how to justify the liability of the defendant.
-
Explore job opportunities at Employment Exchange.
The article provides information on the ninth Employment Exchange (EEX) event to be held by the American Pharmacists Association during its annual meeting and exposition in San Diego, California in 2008. It claims that EEX will provide pharmacists some job opportunities from about 40 participating companies by allowing them to submit their resumes on www.pharmacist.com. Moreover, companies will provide discussions that would help young pharmacists identify their career opportunities.
-
Family Physicians, Pharmacists and OTC Use: A Collaborative Approach.
The article emphasizes the roles of family physicians and pharmacists in spreading information about the use of over-the-counter (OTC) medications. It is claimed that both family physicians and pharmacists can help make patients make good choices about OTC products. Pharmacists can counsel patients about OTC agents, while family physicians can remind their patients about the potential for unintentional overdose and of the risk of interactions with other medications that patients may be taking.
-
Faster, higher, stronger, healthier.
The article reports on the effort of pharmacist Mike Pavlovich to provide care at the 2008 Summer Olympics held in Beijing, China. He served as the US Olympic team pharmacist, offering drug therapy to various athletes. The treatments he provided to American athletes were varied. He cites that there were a lot of acute illnesses that arose as a result of travel and changes in the environment.
-
FDA 'science and mission at risk,' experts say.
The article focuses on the report made by the Food and Drug Administration (FDA) Science Board, which indicates that public health is at risk in the U.S. The board has spent a year investigating the state of FDA's scientific and regulatory programs and their ability to respond to demands. The report shows that the imbalance between FDA's expanding responsibilities and its resources is imposing significant risk to food integrity, drug and cosmetic.
-
FDA approves 2008-2009 influenza vaccines.
The article reports on the approval of the 2008-2009 influenza vaccines by the U.S. Food and Drug Administration (FDA). It includes the Afluria, Fluarix, and FluLaval. It states that the modifications needed for each season's flu vaccine is dictated by the strains expert including Centers for Disease Control and Prevention and the World Health Organization.
-
FDA brochure aims to help patients get the most out of pharmacist counseling.
The article reports on the launching of the brochure "Stop-Learn-Go" issued by the U.S. Food and Drug Administration to ensure the safe use of medicines. It states that its main components include what patients should tell their pharmacist, what patients should ask their pharmacist, and what they should do after they receive their medication but before they leave the pharmacy.
-
FDA clarifies 2009's mandatory "side effects statement".
The article offers information on the interim final rule of Food and Drug Administration (FDA) in the U.S. The interim final rule has called for label listing of 800 number for reporting adverse events. The rule will not apply to over-the-counter (OTC) if the packaging of the products already include toll free number for reporting complaints to the distributors or manufacturers. Moreover, the rule noted that the required labeling has referred to as the side effects statement.
-
FDA improves transparency to drug safety information.
The article reviews the web site www.fda.gov/oc/initiatives/advance/fdaaa.html from U.S. Food and Drug Administration (FDA).
-
FDA kicks off major hiring initiative.
The article outlines the manpower needs of the Food and Drug Administration (FDA) in the U.S. It is recruiting more than 600 new positions and backfill more than 700 others in fiscal year 2008. The new hirees would represent a threefold increase in the agency's manpower needs and to fulfill the FDA Amendments Act of 2007, the Food Protection Plan, and the Import Safety Action Plan. It states that the agency was granted the authority to hire employees directly because of critical need.
-
FDA urges cautious use of topical OTC products.
The article focuses on the precautionary advice of the U.S. Food and Drug Administration (FDA) on consumers concerning the use of topical over-the-counter (OTC) creams and ointments. It relates that the consumer update posted by FDA discusses specific dangers associated with the misuse of methyl salicylate topical preparations and compounded creams and ointments. It notes that the FDA stresses the importance of carefully reading and following instructions for OTC topical products.
-
FDA: Radical changes demand response.
The article reports on the capability of the Food and Drug Administration (FDA) to face the dramatic changes in the worlds of medicine and foods in the U.S. FDA Commissioner Andrew C. von Eschenbach said that he is confident about the agency's ability to adapt to future challenges as part of fulfilling its mission of protecting and promoting public health. He added that pharmacists play an important role in facing these changes in pharmaceutical industry.
-
Fesoterodine: A new agent for overactive bladder.
The article evaluates the fesoterodine (Toviaz) tablet for overactive bladder from Pfizer Inc.
-
Flavocoxid for osteoarthritis.
The article evaluates flavocoxid medical food product from Primus Pharmaceuticals company.
-
Flu doubles risk of heart attack and stroke.
The article reports on the higher risk of myocardial infarction or stroke among patients who experienced 7 days of respiratory infection, such as influenza, as indicated in an article by Tim Clayton and colleagues published in "European Heart Journal." The researchers have found a 2.10 odds ratio for myocardial infarction and a 1.92 odds ratio for stroke. Further details about the results of the research are discussed.
-
Foundation summit addresses workplace depression.
Information about several topics discussed at the 2008 Employer Summit to Address Depression hosted by the APhA Foundation in Orlando, Florida from February 20 to 22, 2008 is presented. Topics include the impact of depression and chronic disease and the strategies that can be adopted to address depression in the workplace.
-
Free drug samples may be poorly used.
The article reports on a study which reveals that not only do free drug samples not go to poor and uninsured children in the U.S. The researchers found that poor children whose family income was less than 200% of the federal poverty level were no more likely to receive free drug samples than children whose family income was more than 400% of the federal poverty level. Additionally, uninsured children were no more likely to receive free drug samples than children with insurance.
-
Fulfilling pharmacy's destiny: A project for the ages.
The author reflects on the scope and mission of the Project Destiny initiative of the American Pharmacists Association, the National Association of Chain Drug Stores and the National Community Pharmacists Association. He remarks that the initiative has a mission to develop a replicable, scalable, and economically viable future model for community pharmacy. He asserts that the initiative seeks to include pharmacy and pharmacists in the management of the complicated and powerful drug regimens.
-
Gans at APhA Builder of a frim foundation for pharmacy.
The article profiles John A. Gans, chief executive officer at the American Pharmaceutical Association (AphA). He has established the association into an organization ready for growth, as well as instituted financial systems and controls to ensure the association's long-term viability. His worked to promote the role of pharmacists worldwide, lays the foundation for future advancements and stability of pharmacy. He aims to enhance and support the profession of pharmacy.
-
Gans to step down after 20 years at APhA helm.
The article reports on the plan of John A. Gans to resign as chief executive officer (CEO) of the American Pharmacists Association (APhA) after completing his service at the APhA in 2009 in the U.S. The plan of Gans has led the APhA Board of Trustees to initiate a search to identify a successor for Gans. For many years, Gans has helped the association to overcome financial difficulties and the increase attention of pharmacists to medication therapy management (MTM).
-
Generics and brand-name drugs: Substitution decisions.
The article discusses federal judge decision on a legal claim by a trade name manufacturer against a generic manufacturer. The judge explained that the trade name manufacturer sent a series of false letters to generic manufacturer's consumers. Thus, it advice pharmacists receiving the false letter that the failure to stop substituting generic product for the trade name product since it would lead to corrective action.
-
Getting the most out of APhA2009.
The article offers information on the APhA 2009 annual meeting &exposition to be held in San Antonio, Texas in April 3-6.
-
Getting to know patients is key to counseling.
The article profiles pharmacists Ginger Mathis and Jennifer Mishkula and how they saved and improved patients' lives. It mentions that both have demonstrated how establishing a personal relationship is essential in providing patient care. It notes that both pharmacists have improved the lives of their patients by taking time of knowing them and understanding their needs.
-
GSK introduces online flu vaccine orders.
The article reviews the web site www.GSKVaccinesDirect.com from GlaxoSmithKline.
-
Guide error prevention efforts with FMEA.
The article focuses on the application of failure mode and effects analysis (FMEA) in reducing the risk of medication errors in pharmacy practice. It mentions that FMEA is a procedure that aims to identify areas of potential failure and measure its effects would be before an error actually takes place. The procedure could be used to asses the potential for error with new medications when they are first marketed or before they are prescribed.
-
Happy golden anniversary, Bowl of Hygeia.
The article reports on the evolution and the significance of the Bowl of Hygeia to the pharmaceutical industry in the U.S. It recognizes the contributions of pharmacists to their communities. According to Thomas J. Croce, in addition to its exceptional contributions, the Bowl recognizes pharmacists for their outstanding community service activities. It was established by E. Claiborne Robins, a pharmacist from Richmond, Virginia and president of pharmaceutical firm A.H. Robins.
-
He said, she said: Finding the evidence when you need it.
The author reflects on the assertion that medicine is for people, not for profits. He cites that the U.S. pharmaceutical industry was viewed as the source of miracle drugs that had helped in the World War II and that government agencies, large companies, health professionals and hospitals had their best interests. He adds that an analysis showing positive results of antidepressant trials were more likely to be published than negative ones.
-
Health benefits of vitamin D.
The article offers information concerning the health benefits of vitamin D. According to research studies, the health benefits of vitamin D have been more positive than those for vitamin E. Vitamin D has been considered a hormone and consists of ergosterol and 7-dehydrocholesterol compounds which are activated through a series of steps that include exposure to ultraviolet B light followed by 25-hydroxylation by the liver and 1-alpha-hyrdoxylation in the kidney.
-
Health care reform: Divided we fail.
The author discusses the issue of health care reform in the U.S. The author looks at the group of bipartisan cooperation who addresses the welfare of senior citizens concerning the quality and security of health care and economic systems in the U.S. He also mentions the responsibility of the pharmacists in collaborating with the health care team as the country's government analyzed the health care system reform.
-
Health professionals may need to pay more attention to prenatal vitamin use.
The article focuses on the study conducted by Gideon Koren and colleagues which determines if iron content in prenatal vitamins was a factor in adherence. The study found no difference in adherence rates between pregnant women with low elemental iron content and high elemental iron content. The study also urges health professionals to consider these complications in developing public health strategies ensure pregnant women to take folate and other vitamin throughout pregnancy.
-
Help patients get their rest.
The article announces that the U.S. Centers for Medicare &Medicaid Services (CMS) has reconsidered the 2005 CPAP therapy National Coverage Determination for obsructive sleep apnea (OSA) to allow coverage of CPAP based on a diagnosis of OSA by home sleep testing. CMS decision may create opportunities for pharmacists to offer home sleep testing devices to patients. OSA involves the repetitive collapse or partial collapse of the airway during sleep, leading to frequent interruptions in breathing.
-
Help your patients make better OTC choices.
The article reports on the revision of the Advancing Patient Self-Care, a national certificate training program, for 2008 in the U.S. Accordingly, the program has been updated in order to educate health care professionals about the safe and effective use of nonprescription medications to help self-treating patients in making appropriate decisions as well as achieving optimal outcomes. Moreover, the revision will include eight self-study modules and a live seminar for applicability.
-
Helping patients 'take charge': Forshee creating new future for pharmacy practice.
The article elaborates the significance of the Take Charge weight control program formulated by Terry Forshee in Cleveland, Tennessee. It is a platform that educates his patients about a healthier lifestyle and encourages them to enjoy weight loss as a result of their better eating and exercise habits. It is a 13-week, one-on-one educational program that emphasizes nutrition and exercise and a menu of functional foods that patients use in changing their diet.
-
History show and tell at APhA2008.
Information about several papers discussed at the American Public Health Association's (APhA's) Annual Meeting &Exposition held in San Diego, California on March 2008 is presented. During the event, a slide presentation was delivered by Eric Jenstsch, Diane Wendt and Ramunas Kondratas. It was undertaken to entertain and educate about the history of the profession and furnish information on the changes that occurred in the field.
-
HONORARY PRESIDENT.
The article announces that Anthony N. Civello is appointed as the American Pharmaceutical Association (APhA) Honorary President for 2008-2009 in the U.S.
-
How to Report an Adverse Event to MedWatch.
The article offers information about the procedures on how to properly report an adverse event to MedWatch Surveillance System of the Food and Drug Administration (FDA) in the U.S. The first step is identify if the event to be reported is serious, clinically important, and has used errors related to drugs, biologics, and medical devices. Others steps include selecting a method for submitting the report and gathering relevant information.
-
HRSA offers new pharmacy grant funding opportunities.
The article reports on the pharmacy expansion grant announced by the Health Resources and Services Administration in the U.S. for fiscal year 2008. It notes that the grant funding will be available for grantees of the Bureau of Primary Health Care which include community health centers, migrant health centers, and public housing primary care. It states that about 40 grants worth $6 million will be awarded on September 1, 2008.
-
ICAAC 2007: Infectious disease update for pharmacists.
The article presents the research findings that were discussed at the 47th Annual International Science Conference on Antimicrobial Agents and Chemotherapy in Chicago, Illinois on September 17-20, 2007. It provides information on the growing concerns of methicillin-resistant diseases caused by Staphylococcus aureus and Clostridium difficile and on the challenges posed by combined vaccines. Meanwhile, it concludes the progression of clinical controversies related to the management of infections.
-
Identifying and managing opioid-induced hyperalgesia.
The article discusses the ways to identify and manage patients with opioid-induced hyperalgesia (OIH). It relates that the OIH may appear as a worsening of existing pain and the emergency of new pain sympoms as hyperesthesia and allodynia. It suggests that rotating the patient to another opioid may provide benefit to some patients with opioid-induced hyperalgesia as well as those with tolerance.
-
In compassion lies your true strength.
The article discusses the significance of reflective listening and empathy to effective communication with patients in the U.S. The first tool refers to the process in which pharmacist takes the opportunity to clarify and understand the patient's feelings and concerns while empathy is the ability to not only understand a patient's words but also understand a patients emotions. These are vital in establishing rapport among patients because through it, patients can freely impart what they feel.
-
Include OTCs in Medication Reconciliation.
The article stresses the role of physicians to see to it that their patients have a balance intake of over-the-charge (OTC) drug and herbal products. Accordingly, physicians must do the supervision in order to have an effective medication reconciliation over the condition of the patient. To do so, the brown bag approach is suggested since it allows physicians to review the medications and dosages as well as check for expired drugs and potential drug-drug interactions.
-
Influenza vaccine for health professionals.
The article reports that influenza vaccination is critical for health care professionals (HCP) to protect themselves, their patients, and their families in the U.S. It states that HCP are at increased risk of infection with the influenza virus because of their frequent contact with infected individuals. Further, Health and Human Services (HHS) urges pharmacists to continue to offer the best and safest care possible by vaccinating themselves and encouraging those they supervise to get vaccinated.
-
Inhaled anticholinergics for COPD.
The article presents a study concerning the effectiveness of the inhaled anticholinergics for chronic obstructive pulmonary disease (COPD) treatment. Research shows that anticholinergics such as ipratropium and tiotropium were associated with increased risk for cardiovascular death in patients diagnosed with COPD.
-
Introduction.
The article discusses the significance of medication adherence to patients in the U.S. It is vital to the treatment of various illness because poor medication and adherence linked to a number of adverse outcomes such as functional abilities, lower quality of life and premature death. Research shows that only an estimated 50% of patients with chronic conditions are adherent to their medication regimens. Discussed are the details of the issue.
-
Is behind ahead? The BTC drug debate continues.
The article discusses the arguments among speakers from various medical organizations in the U.S. concerning the significance of behind-the-counter (BTC) drugs. Michael Mon�E9 of APhA gives emphasis to the benefits of BTC to the public health. On the other hand, Joseph Cranston, director of Science, Research and Technology of the American Medical Association, stresses that prescription should be required for BTC drugs in order to ensure its safety towards patients.
-
JFPS reconvenes in Kentucky.
The article offers information on the 14th Joint Forces Pharmacy Seminar to be held at the Kentucky International Convention Center on November 2-6, 2008.
-
Joint Commission symposium targets medication safety with APhA support.
The article offers information on the medication safety symposium sponsored by the Joint Commission and Joint Commission Resources in Chicago, Illinois from August 5 to 9, 2008.
-
Lacosamide: A novel antiepileptic drug.
The article evaluates the Vimpat lacosamide, an antiepileptic medication from UCB SA.
-
Learing Objectives.
The article discusses the usefulness of the monograph "Appropriate Use of Common OTC Analgesics and Cough and Cold Medications." It is claimed that the said monograph would help participants apply their knowledge of commonly-used over-the-counter (OTC) medications such as analgesics, decongestants and expectorants. It would likewise inform them of various strategies that could mitigate the risk associated with the use of OTC medications in certain population.
-
Learning about how pharmacists learn.
The article presents the assessment of the continuing pharmacy education (CPE) conducted by American Public Health Association (APhA). According to the article, APhA has been conducting the yearly Education Needs Assessments since 2005 and the association aims to gain better understanding on CPE and training needs for pharmacists.
-
Letters from FDA.
The article focuses on the analysis conducted by pharmacists Tom Murry, executive director of the Pharmacy Compounding Accreditation Board on regulatory issues that affects compounding pharmacy in the U.S. It mentions that Murry reviewed ways that pharmacy, the government and how the courts deal with questions about traditional pharmacy practice and appropriate regulatory methods. It notes that Murry reviewed warning letters issued by the Food and Drug Administration and relevant case law.
-
Leukemia &Lymphoma Society provides copay and premium support.
The article offers information on the Co-Pay Assistance Program of the Leukemia &Lymphoma Society (LSS) in the U.S. The program is designed to help low-income patients with diseases, including myeloma, Hodgkin, and acute myelogenous leukemia. Anita Welborn, program administrator, states that the program will offer assistance towards private health insurance premiums and Medicare Advantage premiums. For more information log on to www.lls.org/copay.
-
Leveraging APhA's assets: American pharmacy's corner drugstore.
The author reflects on the new headquarter of the American Pharmaceutical Association (APhA) at the Constitution Avenue in Washington, DC. He asserts that new structure will offer state-of-the-art facilities for the important work of APhA. He cites that it will also provide location that can be used by other entities for networking and professional functions. He points out that AphA will recoup the cost of its investment through long-term leases of space in its new building to the US government.
-
Leveraging pharmacy's most valuable asset in stopping medication errors.
The author reflects on the role of pharmacists in stopping medication errors in the U.S. Due to the prevalence of medication errors, the role of pharmacists and pharmacy technicians were put in limelight. He stressed that if a particular medication is not administered properly, it has a detrimental effect to the patients. Pharmacists played an important role in addressing the problem because they are the designated keepers of medications and they make sure that patients received the right drugs.
-
Liability for dispensing a drug withdrawn from the market.
The article announces that the Supreme Court of Utah has added another exception to the general no duty to warn rule. Accordingly, this exception applies when a pharmacist is alleged to have dispensed a prescribed drug after the drug has been withdrawn from the market by the Food and Drug Administration (FDA). It points out that the duty of pharmacist changes when a drug is removed from the market.
-
Limited data on concomitant warfarin, natural product use.
The article offers information about the use of warfarin and other natural products based on case reports, animal data, and pharmacologic activity in the U.S. The use of Warfarin is to treat venous thromboembolism and prevent stroke in older adults with atrial fibrillation. Natural products such as Vitamin E is used for intermittent claudication and prevention of cardiovascular disease, fish oil for lowering triglycerides, and red clover for menopausal symptoms.
-
Little difference in effectiveness of common osteoporosis drugs.
The article reports on the study conducted by Suzzane M. Cardette and colleagues on the efficacy of nasal calcitonin, raloxifene, alendronate, and risedronate to more than 43,000 Medicare beneficiaries in the U.S. Result reveals that within 12 months of the start of the survey, 1,051 nonvertebral fractures had occurred and there were no significant difference to patients who used these medications.
-
Looking back to plan ahead.
The article shares the author's insights on various issues the pharmacy profession should be prepared to be involved with in 2008 in the U.S. According to her, the Congress has mandated the use of tamper-resistant prescription pad for all handwritten Medicaid prescriptions to outpatients. Moreover, the Congress has also discussed the pay requirement for Medicare Part D plans to be included in the fix bill of the Medicare.
-
Lovastatin, phenylephrine addressed by FDA advisory committees.
The article reports that a joint panel of advisors has urged the U.S. Food and Drug Administration not to approve Merck &Co. Inc.'s proposal to switch lovastatin 20 mg to over-the-counter (OTC) status. The report noted that a vote was cast against the approval, with another vote indicating that the panel did not feel Merck's consumber-behavior study (SELECT) adequately demonstrated that OTC consumers would make the appropriate decision on their own.
-
Low testosterone linked to depression in older men.
The article reports on the results of the study conducted by physician Osvaldo P. Almeida and colleagues regarding the effect of low testosterone in older men in the U.S. In their study of men aged 71 to 89, they found out that men with low testosterone will likely to suffer from depression. The researchers suggest that older men with depression may benefit from systematic screening of free testosterone concentration and testosterone supplementation.
-
Make your message stick.
The article reviews the purpose, process, and payoff of acknowledging and emphasizing key information presented during a medical counseling session. The goal of helping patients understand key issues is to lessen medication misadventures and enhance adherence. Accordingly, acknowledging key points also serves as a checklist for the pharmacist on what should have been covered during the consult and cues the patient that the consult is coming to a close.
-
Making MTM part of the national health IT movement.
Information about the topics discussed at the meeting entitled "Mapping the Route to MTM Documentation &Billing Standardization and Interoperability within the Health Care System" held on October 7-8, 2008 in Bethesda, Maryland is presented. It explores strategies for standardizing documentation and billing for medication therapy management (MTM) services. The meeting featured leaders from diverse settings, including national pharmacy associations, health plans, and government agencies.
-
Making the switch.
The article announces that albuterol inhalers that use chlorofluorocarbons (CFCs) are being phased out and will no longer be available for sale after December 31, 2008 in the U.S. Accordingly, patients who now use albuterol inhalers containing CFCs will need to switch to alternative albuterol inhalers that contain a propellant called hydrofluoroalkane (HFA). It suggests that pharmacists should be aware of the various differences between HFA and CFC inhalers.
-
Marciniak honored with Prescott Pharmacy Leadership Award.
The article announces that Macary Weck Marciniak has received the 2008 Albert B. Prescott Pharmacy Leadership Award given by the Pharmacy Leadership &Education Institute.
-
Mckesson program helps independents maximize reimbursement.
The article reports that the McKesson Reimbursement Advantage (MRA) program of McKesson Corp. has helped 150 independent pharmacies acquire $1,960 reimbursement in January 2008. It mentions that the results indicate that the program is successful at maximizing net profits for the McKesson clients. It notes that the MRA program includes a comprehensive reimbursement package of financial services, such as automated claims resubmission to capture price increases and analytics services.
-
Measuring success in your MTM practice.
The article offers information on how to identify specific measurable outcomes in gauging the success of implemented medication therapy management (MTM) practice in the U.S. According to the Joint Commission's Clinical Value Compass to measure growth and success, MTM practitioners must apply the categorized health-related outcomes like patient satisfaction and health-related quality of life and others. A successful MTM practice reaps outstanding patient satisfaction as well as gained revenues.
-
Medicare drug plan price hikes exceed inflation.
The article focuses on the research which indicates that three-fourths of Medicare drug plans continue to raise their prescription medication prices. The plans increased prices for commonly used drugs by an average of $369 from December to January 2008. In addition, the research uses Medicare's Web site in tracking the cost of five prescriptions offered by private Part D drug plans in five states in the U.S.
-
Medicare Part D update: Key information for 2009.
The article presents updates concerning the benefit comparison between the Standard Medicare Part D in 2008 and 2009 in the U.S. According to the article, pharmacists can now assist Medical beneficiaries in reviewing the current Medicare for 2009. It highlights the difference between the Medicare of 2008 and 2009, particularly in the changes made for the coverage.
-
Medicare Part D: Not just for geriatric use.
The article examines the medications covered by Medicare Part D. It suggests that Part D plans must cover an array of drugs that will meet the needs of both younger and older patients. Centers for Medicare &Medicaid Services requires that Part D formularies include virtually all drugs in the immunosuppressant, antidepressant, antipsychotic, anticonvulsant, antiretroviral, and antineoplastic classes. It also recommends that multiple strengths and dosage forms be available for each covered drug.
-
Medication adherence pilot program kicks off in California.
The article reports on the collaboration among InnovationRx company, American Pharmaceutical Association, US Food &Drug Administration Office of Women's Health, and Pharmacist Planing Service Inc. to promote medication adherence. The move offers pharmacists with resources that can help them encourage adherence in its patients. InnovationRx pledged to raise awareness of the consequences of non-adherence and showcase programs that are available to help patients simplify their medication regimen.
-
Meeting patients' special needs a priority for One to One honorees.
The article profiles Debra Pruss and Angel Stivers in the U.S. Pruss is a pharmacist who is trained to provide specialized, in-depth health monitoring and counseling services directly to patient care and who regularly travels between her base store in Raleigh, North Carolina and other vicinities to meet with patients and review medication regimens. Stivers is also a pharmacists who always takes first step in providing care.
-
Meeting the challenge to deliver MTM: Pharmacist networks.
The article reports on the significance of the pharmacist networks to meet the challenges in delivering medication therapy management (MTM) in the U.S. The networks are developed to meet the needs of a payer, including the availability of enough pharmacists to provide care to patient and a mechanism to ensure the quality of the care provided. It suggests that a network with an administrative team that works closely with the payer will provide an opportunity to pharmacists to participate in MTM.
-
Mending medication mix-ups.
The article focuses on the study by the United States Pharmacopeia (USP) compendia regarding the major causes of medication errors in the country. The MEDMARX Data Report stated that medication errors were caused by similarities between the brand or generic names. In fact, USP compiled a list of 3,170 look-alike and sound-alike drug name confusions.
-
Methodology.
The article presents statistics concerning the number of times that pharmacists are recommending nonprescription drugs every week to consumers in the U.S.
-
Minding your Rs and Ps.
The article shares the lessons learned by the attendees during the Annual Meeting &Exposition of American Pharmacists Association (APhA) in 2008 in San Diego California. According to the author, the attendees learned three Rs which refer to relationships, recognition, and responsibility and Ps for presence, progress, and pride. He added that these six words put into perspective the value found by patients in pharmacists and the importance of pharmacists working together through APhA.
-
Minnesota legislature, Board of Pharmacy target Webbased pharmacies.
The article reports on the enactment of a law in Minnesota making it illegal to dispense drugs based on online questionnaires. It states that the move was in response to the death of Justin Pearson which was attributed to prescription drugs he had obtained from online pharmacies. The state board of pharmacy has investigated the Market Pharmacy based on alleged connections with the death of Pearson.
-
Monograph Quiz Information.
The article explains the usefulness of the online Monograph Quiz. It is claimed that the online Monograph Quiz can be used by any physician seeking American Academy of Family Physicians (AAFP) continuing medical education (CME) credit. Other than physicians, pharmacists can likewise make use the said Quiz as they would be given a Statement of Credit if they attain a passing grade of 70 percent or better.
-
More confusion between opium tinctures.
The article focuses on several issues regarding opiate overdoses caused by accidental mix-ups of opium tinctures and camphorated opium tincture (COT). It is stated that these drugs are considered as high-alert medications that have a high risk of patient harm when used in error. Moreover, the factors that could lessen the errors include eliminating opium tincture in the inventory, using paregoric as the official name for COT, and educating colleagues and students about the medications.
-
More drug name confusion.
The article presents cases of drug name confusions that resulted to the erroneous administration of medications on patients. The errors happened due to poor handwritings that are eventually misinterpreted by pharmacists. It therefore cited the need for pharmacists and nurses to verify the purpose of the prescriptions passed to them and to educate patients about their medications. Moreover, it considered the need for patients to update the drugs they have been taking.
-
More reasons to keep oral syringes in stock.
The article reports on the recommendation by the US Institute for Safe Medication Practices (ISMP) that parenteral syringes never be used for oral liquids and that practice sites stock several sizes of oral syringes for distribution or purchase. The move is due to the report it received that one infant died and others have been injured when they swallowed or choked on syringe caps. It suggests that pharmacists should demonstrate proper device use and ask the patient to show proper use in return.
-
MTM care for seniors: Pharmacy's opportunity, pharmacists' imperative.
The author reflects on the need of pharmacists to learn more about geriatrics and gerontology to meet the demand of growing number of older populations. He contends that as the baby boomers begin reaching their senior years, pharmacists need to know about health care and medication of the elderly through continuing education and certificate training programs. He argues that it is not enough for pharmacists to know how to provide medication therapy management when elderly is concerned.
-
MTM guidance, research served up at APhA2008.
Information about the 2008 annual meeting &exposition of the American Pharmacists Association (APhA) held in San Diego, California is presented. It mentions that the meeting offered pharmacists, student and technicians the opportunity to learn, celebrate the profession and network during the activity. It notes that the event provided a veritable cornucopia of medication therapy management (MTM)-centered educational offerings and tools to expand and refine attendees' MTM practices
-
MTM visits: Enhancing the patient experience.
The article offers information on the medication therapy management (MTM) service in the pharmacy practice, and how it can be enhanced to ensure a positive experience for the patient. It relates that MTM is a patient-centered service that addresses the needs of the individual to ensure that appropriate care is being received. The author notes that pharmacists providing MTM services should consider planning ahead before the visit to ensure an efficient and productive meeting.
-
MTM: 'An emerging movement with great potential'.
The article reports that the American Pharmacists Association (APhA) Annual Meeting and Exposition has released the paper "Medication Therapy Management (MTM) in Pharmacy Practice: Core Elements of MTM Service," Version 2.0 in the U.S. The new document has been created in collaboration with the National Association of Chain Drug Stores (NACDS) foundation. NACDS was responsible for updating the original 2004 version which provided the foundational framework for the improvement of MTM programs.
-
MTM: Making the most of a new year.
The author provides information on the significance of the medication therapy management (MTM). He mentions the effectiveness of MTM in bearing the latest paradigm to health care system, community, and managed care pharmacies in the U.S. In addition, the author challenges the pharmacists to practice the MTM services.
-
MTM: The pieces fit together.
The article discusses various reports published within the issue, including one by J. Lyle Bootman on the mortality rate among ambulatory Americans, and another by Marilyn Stebbins on medication therapy management (MTM).
-
Multifaceted strategic communications plan for APhM.
The article focuses on the works of the American Pharmacists Month (APhM). It states that the center of services will be placed on medication therapy management (MTM) that will promote safe and effective use of medications and help patients achieve targeted health outcomes. It notes that the APhM message will help patients evolve their understanding of pharmacists as being a critical member of the health care team.
-
NABP helps separate the good from the bad in online pharmacy.
The article reports that the National Association of Boards of Pharmacy (NABP) has launched a special section on its website for Internet pharmacies in the U.S. The special section is designed to help pharmacies in determining good from bad in online pharmacy. It offers two lists of websites, one with pharmacies accredited through the NABP Verified Internet Pharmacy Practice Sites (VIPPS) program and another with pharmacies identified as not recommended.
-
Narrowing the gap between science, practice.
The article focuses on the federal initiative by the Department of Health and Human Services (HHS) which ensures physicians and patients to have an appropriate information about a certain drug in the U.S. Through this program, pharmacists will continue to have an important role in improving the quality and safety of patient care. According to the physician Kristin Brinner, HHS is not only looking at patients and physicians but also pharmacists, nurses and other practitioners.
-
Nationwide Asthma Screening Program kicks off in May.
The article announces the start of the 12th annual Nationwide Asthma Screening Program of the American College of Allergy, Asthma, and Immunology in May 2008 in the U.S. The program will offer free allergist-conducted screenings to patients with breathing problems or already diagnosed with asthma. The program is sponsored by AstraZeneca PLC and supported by the Asthma and Allergy Foundation of American and the Allergy and Asthma Network Mothers of Ashmatics.
-
Natural products for people taking prescription drugs.
The article evaluates the Rx Essentials natural products dietary supplements for individuals using prescription drugs from Nature Made.
-
Natural tools to fight osteoporosis.
The article offers information on the measures to be taken to eliminate the risk factors of developing osteopenia and osteoporosis. It cites that patients should be encouraged to take enough calcium and vitamin D either through supplements or dietary sources. Moreover, it is noted that the first-line therapy for preventing and treating osteoporosis is bisphosphonates as most of these drugs lessen vertebral and hip fractures.
-
Nebivolol: A third-generation beta-1 blocker.
The article offers information on Nebivolol, a beta-1 selective adrenergic blocker indicated for treatment of hypertension. It cites that Nebivolol has no intrinsic sympathomimetic activity, but it has higher degree of beta-1 selectivity compared with the current marketed beta-1 blockers. Moreover. it is noted that Nebivolol has also been examined for the treatment of coronary failure.
-
New APhA slate elected.
The article announces several elected officers for the American Pharmaceutical Association including Harold N. Godwin as president, Steven T. Simenson as member of the board of trustees, and Walter G. Chambliss as president of APhA Academy of Pharmaceutical Research and Science.
-
New APhA slate elected.
The article announces several elected officers for the American Pharmaceutical Association including Harold N. Godwin as president, Steven T. Simenson as member of the board of trustees, and Walter G. Chambliss as president of APhA Academy of Pharmaceutical Research and Science.
-
New drug may slow Alzheimer-induced functional decline.
The article reports on the study conducted by Gordon K. Wilcock and colleagues on the significance of Tarenflurbil, a new selective amyloid-beta-42-lowering agent (SALA) used in treating patients with Alzheimer's disease in the U.S. It shows that the substance can improve cognition and function in patients, wherein those treated with 800 milligrams of tarenflurbil displayed a significantly lowered rates of decline in activities of daily living and global function scores compared to placebo.
-
New labeling for nonoxynol 9 OTC contraceptives out in June.
The article elaborates the new ruling imposed by the Food and Drug Administration on the labeling of nonoxynol 9 (N9) over the counter (OTC) vaginal contraceptive and spermicidal products in the U.S. The agency imposed a new ruling that requires manufacturers to incorporate the updated warning in the labels of these products intended to warn patients that N9 does not protect against HIV/AIDS or other STD and may increase the risk of getting HIV from an infected partner.
-
New laws to promote pain management.
The article provides information on the latest laws for the promotion of pain management in the U.S. Such pain management laws include Veterans Pain Care Policy Act, Military Pain Care Policy Act of 2008, and the National Pain Care Policy Act of 2008. Inasmuch, the three new laws may affect the pain care provision and medication in the country particularly in analgesic treatments and pharmacy services for patients with chronic and acute pain.
-
New osteoarthritis drug relieves pain, causes fewer Gl adverse effects.
The article focuses on Tapentadol, an investigational pain medication that relieves pain and causes fewer gastrointestinal adverse effects. It offers osteoarthritis patients a substantial pain relief compared with other prescription pain reliever. The Phase III of the clinical study of the drug, funded by Johnson &Johnson Research &Development, showed that patients treated with tapentadol experienced relief. The drug, if approved will be marketed by PriCara, a division of Ortho-McNeil Inc.
-
New practitioner honored by Choice USA for training and education initiative.
The article announces that Asal Sadatrafei has received the Choice USA GENERATION Award.
-
New therapeutic agents marketed in the first half of 2008.
Objective: To provide information regarding the most important properties of the new therapeutic agents marketed in the first half of 2008. Data sources: Product labeling supplemented selectively with published studies and drug information reference sources. Study selection: By the author. Data extraction: By the author. Data synthesis: The ten new therapeutic agents marketed in the United States during the first half of 2008 are reviewed in this article: etravirine, sinecatechins, nebivolol hydrochloride, desvenlafaxine succinate, ciclesonide, certolizumab pegol, methylnaltrexone bromide, alvimopan, bendamustine hydrochloride, and rilonacept. Indications and information on dosage and administation for these agents are reviewed, as are the most important pharmacokinetic properties, adverse events, drug interactions, and other precautions. Practical considerations for the use of the new agents are also discussed. When possible, the properties of the new drugs are compared with those of older drugs marketed for the same indications. Conclusion: A number of the new therapeutic agents marketed in the first half of 2008 have important advantages over older medications. An understanding of the properties of these agents is important for the pharmacist to effectively counsel patients about their use and to serve as a valuable source of information for other health professionals regarding these drugs.ABSTRACT FROM AUTHORCopyright of Pharmacy Today is the property of American Pharmacists Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.
-
New therapeutic agents marketed in the second half of 2007.
Objective: To provide information regarding the most important properties of the new therapeutic agents marketed in the second half of 2007. Data sources: Product labeling supplemented selectively with published studies and drug information reference sources. Study selection: By the author. Data extraction: By the author. Data synthesis: The eight new therapeutic agents marketed in the United States during the second half of 2007 are reviewed in this article: doripenem, maraviroc, raltegravir, lanreotide, ixabepilone, nilotinib, temsirolimus, and sapropterin dihydrochloride. Indications and information on dosage and administration for these agents are reviewed, as are the most important pharmacokinetic properti'es, adverse events, drug interactions, and other precautions. Practical considerations for the use of the new agents are also discussed. When possible, the properties of the new drugs are compared with those of older drugs marketed for the same indications. Conclusion: A number of the new therapeutic agents marketed in the second half of 2007 have important advantages over older medications. An understanding of the properties of these agents is important for the pharmacist to effectively counsel patients about their use and to serve as a valuable source of information for other health professionals regarding these drugs.ABSTRACT FROM AUTHORCopyright of Pharmacy Today is the property of American Pharmacists Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.
-
New thrombosis guidelines released.
The article reports on the release of the 8th edition of Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines in the U.S. The guideline contains the comprehensive information on the prevention, treatment, and long-term management of thrombotic disorders. It also discusses the management of patients on thrombotic therapy who require surgery, as well as added information on preventing and managing thrombosis in pregnant women.
-
New website helps pharmacists collaborate on sterility and potency tests.
The article reviews the Web site www.sterilityandpotency.com.
-
Nicotine addiction reaches 15-year high.
The article reports on the acceleration of nicotine addiction within 15 years. A data presented during the 74th annual international scientific assembly of the American College of Chest Physicians shows that almost 75% of people who are seeking tobacco addiction medication are identified as highly dependent on nicotine. In addition, nicotine dependency has increased 12% since 1989 and 32% for proportion of individuals who are classified as nicotine dependent.
-
Nilotinib: A tyrosine kinase inhibitor for CML.
The article reports on the approval of the Nilotinib drug, a tyrosine kinase inhibitor, manufactured by Novartis AG in the U.S. This drug was approved by the Food and Drug Administration for the treatment of chronic and accelerated-phase Philadelphia chromosome-positive chronic myelogenous leukemia (CML) in adults resistant or intolerant to prior therapies including imatinib.
-
No 'I' in 'pharmacy'.
The article profiles pharmacist Stacey Frede. It mentions that as a residency coordinator for Kroger Pharmacy in Cincinnati-Dayton region in Ohio, Frede understands how important teamwork in providing excellent patient care. Frede also works with a team of pharmacists that provides patient care services ranging from medication therapy management to personalized fitness and nutrition education to pharmacies throughout the region.
-
No right to sue for switch of emergency contraceptive to OTC status.
The article reports on the case filed by several organizations against the Food Drug and Administration (FDA) and the sponsor of the emergency contraception product known as Plan B in the U.S. It is averred that the organizations challenge the agency's approval of the supplemental new drug application (SNDA) for the product. The solution of the lawsuit has significance for the emerging category of behind-the-counter (BTC) medications.
-
Noted pharmacist elected to Institute of Medicine.
The article announces that Milap Nahata was elected to the Institute of Medicine (IOM) of the National Academies of Science.
-
OIG exclusions list: Sounding alarm for awareness.
The article reports on the concerns over the U.S. Office of Inspector General (OIG) exclusions lists. It encourages members of the American Pharmaceutical Association (AphA) to check the list regularly, as hiring a pharmacist who has been excluded from participating in any federal program could result in stiff penalties. AphA concerns on the lack of discretion by OIG in determining who should be included on the list, thus, the association works with Congress to identify the opportunities.
-
Olmesartan may help aggressive hypertension treatment.
The article focuses on the angiotensin receptor blockers that may help in treating aggressive hypertension. The drugs, Benicar (olmesartan) and Benicar HCT (olmesartan/hydrochlorothiazide) are from Daiichi Sankyo Co. The drugs were able to help patients suffering from stage one hypertension by reducing blood pressure.
-
Omega-3 fatty acid supplementation for chronic heart failure.
The article reports on the effectiveness of omega-3 polyunsaturated fatty acids (PUFA) to treat patients with cardiovascular diseases in the U.S. It cites a study which reveals that PUFA through the use of fish oil supplementation has significantly decreases the risk of death by 9% after a myocardial infarction. It also suggests pharmacists to counsel patients that heart failure remains a serious cardiac disease that needs careful monitoring by their cardiologist.
-
Online physician-patient relationships.
The article presents a court case concerning a physician who provided inappropriate medical services and inadequate care over the Internet in Arizona. According to the Arizona Medical Board, the physician was found guilty of issuing prescriptions over the Internet without conducting physical examination and establishing a physician-patient relationship. The result of this case helps preserve the option of treating existing patients through telemedicine.
-
Osteoporosis-related fracture leads to serious long-term costs.
The article reports on the study which reveals that osteoporosis fractures in Medicare patients lead to serious long-term costs. The study consisted of a retrospective analysis of more than 30,000 female Medicare patients aged 65 years and older. The researchers recorded Medicare costs for each six-month period following the fracture to determine the expenses. Patients with wrist, hip, humerus, and clavicle fractures experienced continuous excess medical expenditures throughout the three years.
-
OTC drug abuse on the rise among U.S. teens.
The article reports on the abusive use of over-the-counter (OTC) drugs among teenagers in the U.S. According to a report, about two million to four million teenagers in the country have been abusing such drugs due to fear of breaking the law or because of the expensiveness of illicit substances which they could not afford to buy. It has been stressed that dextromethorphan, a cough suppressant drug, is the commonly abused OTC drugs by such youngsters in order to get high.
-
OTC Medications: The FDA's Classification Criteria.
The article provides the criteria followed by the U.S. Food and Drug Administration as far as over-the-counter (OTC) medications are concerned. These criteria consider, among which, the medication's side effects at therapeutic doses, the administration of these OTC drugs and the product's label in which the average consumer can read and understand the indication. Aside from these criteria, the FDA is likewise exploring the idea of creating a behind-the-counter criteria.
-
OTC product: AcetaDrink.
The article evaluates Acetaminophen analgesic by St. Paul Brands company.
-
OTC Product: EarCheck Middle Ear Monitor.
The article evaluates the EarCheck Middle Ear Monitor from Innovia Medical LLC.
-
OTC product: Emuprofen.
The article evaluates the Emuprofen pain reliever from Progressive EMU Inc.
-
OTC product: NeilMed Saline Nasal Wash.
The article evaluates NeilMed Saline Nasal Wash Kits from NeilMed Pharmaceuticals Inc.
-
OTC product: Turns QuikPak.
The article evaluates the Tums QuikPak instant dissolve powder for heartburn relief from GlaxoSmithKline Consumer Healthcare Ltd.
-
OTC product: Vagisil Screening Kit for vaginal infections.
The article evaluates the Vagisil Screening Kit from Combe Inc.
-
OTC product: VSL #3: The Living Shield.
The article evaluates the VSL #3 probiotic from VSL Pharmaceuticals company.
-
OTC Products and Certain Patient Groups.
The article provides various over-the-counter (OTC) products and their corresponding dosages depending on patient groups. Single doses of acetaminophen and ibuprofen are allegedly safe and effective for treating moderate to severe pain and fever in children younger than 18 years old. Elderly patients are warned of taking pseudoephedrine and phenylephrine as these drugs can allegedly elevate blood and intraocular obstruction.
-
Participate in the political process with APhA-PAC.
The article focuses on the roles of the American Pharmacists Association Political Action Committee (APhA-PAC) to the pharmaceutical industry. It states that the core mission of the APhA-PAC is to provide support to candidates for national office who have showed a strong commitment to pharmacy issues. The contributions provide APhA members with increased access to members of Congress and the chance to speak directly on the issues surrounding the industry.
-
Patient care technician role can enhance MTM services.
The article offers information on the significant role of patient care technician in the U.S. It cites that patient care technician can offer worthful assistance of establishing effective and efficient medication therapy management (MTM) service. Moreover, it is noted that developing the role of patient care technician has a great potential to improve the MTM service by enabling the work more effectively and efficiently.
-
Patient counseling recognized through One to One program.
The article announces the 2008 one to one patient counseling award given to pharmacists in the U.S. including Tina Li Fiebelkorn and Lynne Lee.
-
Patient Factors in Misuse of OTC Medications.
The article discusses various patient-related obstacles that must be addressed to control misuse of over-the-counter (OTC) medications. These obstacles, accordingly, include overestimation and disregard of potential adverse effects, lack of understanding about combination products and inability to accurately self-diagnose. To resolve these obstacles, physicians are advised to OTC medications with patients and discuss with them key points like the appropriate dosage and the use of the medication.
-
Paving the way for high-quality health care.
The article discusses the plans of Pharmacy Quality Alliance (PQA) for 2008. They include the continuance of PQA's approved quality measures for pharmacy services and the finalization of a consumer satisfaction survey for pharmacist/pharmacy services in the first quarter of 2008. PQA likewise intends to develop concepts needed in performing demonstration projects and to create educational programs that would help broadcast its messages effectively.
-
Payment for Knowledge.
A response by Hrant Jamgochian to a letter to the editor about his article "Payment for Knowledge," in the October 2007 issue is presented.
-
PBRNs: A golden opportunity for pharmacy.
The article highlights the pharmacy practice-based research networks (PBRN) in the U.S. published within the issue of the "Journal of the American Pharmacists Association." The Agency for Healthcare Research and Quality defines PBRN as a group of ambulatory practices chiefly devoted to the primary care of patients and to developing the quality of primary care. It features several articles that describe various PBRNs implemented at the local, regional or national health facilities.
-
Pediatric coughs, colds: Nothing proven effective, safe?
The article focuses on the issue about the efficacy and safety of over-the-counter (OTC) cough and cold drugs to children. According to the article, much attention has been given to the issue since the Center for Drug Evaluation and Research (CDER) Nonprescription Drugs Advisory Committee did not specify its recommendation for the efficacy of the drugs in children below and above six years old. Meanwhile , several recommendations for appropriate use of the drugs for pediatrics are discussed.
-
Pennsylvania students take steps to fight diabetes.
The article outlines the moves undertaken by students to fight diabetes in Haverford Township, Pennsylvania. It states that through the Peds for Prevention program, 2,700 students and staff members at five elementary schools took up walking in April 2008 as a measure in preventing diabetes. The program was cosponsored by the Focus Pharmacy, an online pharmacy provider, wherein it donated a total of $25,000 in grant monies, pedometers and educational materials.
-
Personal health records pilot program set to launch in 2009.
The article announces the upcoming launching of the personal health records (PHRs) pilot program in January 2009. According to the article, the said launching of the PHR pilot program was announced by the CMS Co. and cites that it will apply to several patients with Original Medicare, who are residing in Utah and Arizona. In addition, in using the pilot program, the patients can now select between HealthTrio and Google Health web sites.
-
Pharmacists get a taste of health care debate.
The article reports on the plans of two U.S. presidential candidates concerning America's health care system. Senator Barack Obama offers coverage similar to the Federal Employees Health Benefits Program (FEHBP) to the public, including the uninsured, self-employed, and small businesses. However, Senator John McCain plan proposes to find cost savings by using health information systems and treating chronic conditions.
-
Pharmacists' considerations when serving Amish patients.
Objectives: To introduce historical and sociocultural influences on health and health care decisions that should be considered by pharmacists and other health professionals when serving Amish patients and to describe the roles of pharmacists in working with Amish populations, as an example of culturally and linguistically appropriate care. Setting: Community independent pharmacy in Arthur, IL, from 1991 to 2008. Practice description: Reflections of a pharmacist-owner whose community practice serves a sizeable Amish population. Case summary: The Old Order Amish are a religious group that values health and actively participates in its health care decisions. The Amish possess a strong sense of community responsibility and often seek advice of friends, family, and community in health care decisions. Their explanatory models of health and illness differ, in some respects, from the larger American society. The Amish are open to the use of folk medicine, complementary and alternative medicine, and conventional care when deemed necessary. They are receptive to health care information and explanations of options from trusted sources and use increased self-care modalities, including herbal remedies. Results: Knowledge of salient cultural differences is important, but care should be given to avoid stereotyping patients because Amish rules and customs differ across districts. Culturally competent pharmacist care should be individualized based on patient needs and in consideration of aspects of differences in Amish cultures and districts. When serving Amish patients, special consideration should be given to addressing potential barriers to health care use, such as unique dialects, affordability issues for largely cash-paying customers, lower prenatal care use, and lower vaccination rates. Conclusion: Enhanced awareness and sensitivity to Amish lifestyles and beliefs can lessen misconceptions and minimize barriers that interfere with optimal provision of patient-centered pharmacy care and services. By working through established community norms, building trust, and effectively applying cultural competency techniques, pharmacists can best serve the Amish communities.ABSTRACT FROM AUTHORCopyright of Pharmacy Today is the property of American Pharmacists Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.
-
Pharmacists' fate in health care reform: Arkansas coalition could be pivotal.
The article focuses on the possible condition of the community pharmacy after the reformation of the health care system in Arkansas. According to the article, Congressman Marion Berry asserts to save the community pharmacies in the U.S., particularly in Arkansas and cites his statement on the expansion of several pharmacists' role.
-
Pharmacists, students honored for outstanding care.
The article reports that the journal "Pharmacy Today" recognizes pharmacists and student pharmacists in providing outstanding patient care as part of the 2008 One to One Patient Counseling Recognition Program. Johnson and Johnson/Merck Consumer Pharmaceuticals Co. and McNeil Consumer Healthcare support the program. Profiles of the pharmacist awardees will be featured in the journal while profiles of student pharmacist awardees and honorable mentions are featured in Annual Meeting News.
-
Pharmacists: Physicians' best partners.
The author reflects on the relationship between physicians and pharmacists. He refers to the duties of health care professionals in the delivery of health care services. He argues that taking medications is the responsibility of the patient and any caregivers involved in the patients' activities of daily living. He concludes that physicians and pharmacists are the most accessible pair of health professionals.
-
Pharmacy 2.0.
The article reviews the web site RxWiki (www.rxwiki.com) created through the collaboration of Mirixa Corp., the National Community Pharmacists Association (NCPA), the National Alliance of State Pharmacy Associations (NASPA) and American Pharmacists Association.
-
Pharmacy at the forefront of patient safety.
The article elaborates the significance of Patient Safety and Clinical Pharmacy Services Collaborative (PSPC) to the pharmaceutical industry in the U.S. The organization was formed to unify health professionals from all care settings to augment the services and safety offered to patients. The three goals of PSPC include improve health outcomes for the patients it serves, improve the safety of the care it provides, and increase clinical pharmacy services.
-
Pharmacy loses a heroine.
An obituary for Gloria Niemeyer Francke, a doctor of pharmacy, is presented.
-
Pharmacy prospers in the Buckeye State.
An interview with Bryan Coehrs, doctor of pharmacy and director of Clinical Pharmacy at the Pharmacy Center, is presented. He talks on the value of medication therapy management (MTM) and the plan of the firm in utilizing MTM services. He discusses the importance of developing relationships with health care providers. According to Coehrs, he believes that a focus on advice and patient care can ensure that community pharmacy will endure.
-
Pharmacy vaccine update.
The article offers information on the proposed pandemic flu draft guidance and changes in Medicare vaccine reimbursement issued by the federal government in the U.S. The proposal will intend to lessen the impact on health and minimize disruption to the economy in the event of influenza pandemic. Moreover, it is noted that pharmacists are not included in the draft guidance as identified priority health care and community support services group.
-
Pharmacy's future in a turbulent world.
Information about the topics discussed at the 2008 annual meeting of the American Association of Colleges of Pharmacy held in Chicago, Illinois is presented. Topics include the future of pharmacy as the country faces economic crisis. The meeting featured Jonathan Peck of the Institute for Alternative Futures.
-
Phenylephrine: An Effective Substitute?
The article considers phenylephrine as an effective substitute for pseudoephedrine, which has been regarded to be the only oral decongestant commonly found in over-the-counter (OTC) cough and cold medications. The Nonprescription Drugs Advisory Committee of the Food and Drug Administration of the U.S. is allegedly tackling several studies which can claim that phynelephrine is effective in treating nasal congestion in adults who have the common cold.
-
Pneumonia vaccination leads to healthier kids, cuts health care costs.
The article reports on the study conducted by Fangjun Zhou and colleagues which found that rates of hospitalization due to pneumonia declined more than 50% and rates of ambulatory visits due to pneumonia declined more than 40% in the U.S. The study, which was published in the December 2007 issue of "Archives of Pediatrics &Adolescent Medicine," has determined that the decline was due to the pneumococcal vaccination of children younger than 2 years of age.
-
Poison prevention and treatment in the safety net.
The article reports on the funding provided by the Health Resources and Services Administration (HRSA) Poison Control Program to stabilize the foundation of and increase access to poison control center (PCC) services across the U.S. It states that the funds encourage and facilitate collaboration to improve poison education, prevention, treatment and to provide technical assistance. Also, PCCs provides community education and offer continuing education for health professionals.
-
Potential Adverse Events.
The article discusses various potential side effects upon the use of over-the-counter (OTC) medications. These side effects include gastrointestinal effects, which can allegedly from relatively mild dyspepsia to more severe problems such as gastrointestinal hemorrhage. Another are renal effects, including edema and weight gain. Hepatotoxicity is likewise mentioned, which is allegedly likely to suffer by those who take high doses of aspirin.
-
Potential role for cinnamon in type 2 diabetes treatment.
The article reports on the significance of cinnamon in the treatment of type 2 diabetes in the U.S. Studies show that more than 20 million Americans have either type 1 or type 2 diabetes, wherein an additional 54 million have prediabetes. Only 30% to 40% of these people have a good glycemic control, with glycosylated hemoglobin (AIC) value less than 7%. Researchers found that cinnamon cassia may have greater effects on glycose and insulin concentrations than other types of spices.
-
Potential roles for pharmacists in pharmacogenetics.
Objectives: To highlight areas of pharmacogenetics in which pharmacists may play a role and to describe those roles in the context of specific examples from a major academic medical center. Data sources: Literature search (PubMed) and personal interviews for the University of California at San Francisco case examples. Data synthesis: The field of pharmacogenetics presents a wide range of opportunities for pharmacists. Specific roles for pharmacists are likely to fall within three major domains: developing research methodologies and setting research directions, establishing the value of pharmacogenetic testing in clinical practice, and participating in education and infrastructure development that moves pharmacogenetic technologies toward implementation. Conclusion: As drug therapy experts, pharmacists are in a unique position to push the frontiers of pharmacogenetics in both the research and clinical practice environments.ABSTRACT FROM AUTHORCopyright of Pharmacy Today is the property of American Pharmacists Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.
-
Potentially lethal fungal disease linked to TNF blockers.
The article reports on the request by the U.S. Food and Drug Administration (FDA) to manufacturers of tumor necrosis factor-alpha (TNF) blockers to strengthen the risk of infection warning on their products. It relates that TNF blockers are immunosuppressant drugs used to treat various type of arthritis, including rheumatoid, juvenile idiopathic, and psoriatic. The request was due to the concerns that health professional are not consistently recognizing the signs and symptoms of the diseases.
-
Prepare now for CFC inhaler phase-out.
The article elaborates the phase out of chlorofluorocarbon (CFC) albuterol inhalers by the Food and Drug Administration (FDA) in the U.S. Because of such move, the American Public Health Association (APhA) and other organizations are urging pharmacists to begin switching patients to hydrofluoroalkane (HFA) inhalers to avoid problems. Such decision stems from an international agreement established through the Montreal Protocol on Substances that Deplete the Ozone Layer and the Clean Air Act.
-
Preparing health care for baby boomers' golden years.
The article focuses on the report issued by Institute of Medicine (IOM) which indicates that the U.S. health care workforce is not prepared for an anticipated growth of elderly population in the country. It mentions that the committee who produced the report have identified shortages in many geriatric care specialties and emphasized the need for immediate increase in the number of workers who care for older patients. The committee offers specific recommendations to address the problem.
-
Prescription drug importation: The silent threat.
The article discusses the issue about prescription drug importation which remains of interest to many Members of the Congress in the U.S. According to the author, the effects of prescription drug importation can be seen in the news on counterfeit food and drugs. However, despite these effects the American Pharmacists Association (APhA) still believe that importation would facilitate patients obtaining medications from multiple sources.
-
product showcase.
The article offers news briefs related to the pharmaceutical industry. The U.S. Food and Drug Administration (FDA) has approved rotavirus vaccine, Rotarix by GlaxoSmithKline for the prevention of rotavirus gastroenteritis in infants and children. Abatacept from Bristol-Myers Squibb Co. has received FDA approval for the treatment of polyarticular juvenile idiopathic arthritis. Sandoz Pharmaceutical Corp. introduced Omnitrope Pen 5 liquid cartridge drug delivery system for its somatropin product.
-
product showcase.
The article evaluates several medications approved by the Food and Drug Administration (FDA) including olopatadine (Patanase) by Alcon, methylnaltrexone (Relistor) from Wyeth and regadenoson (Lexiscan) by CV Therapeutics and Astellas.
-
product showcase.
The article offers news briefs related to therapeutic drugs in the U.S. The Food and Drug Administration (FDA) has approved Alvesco inhalation aerosol for maintenance and prophylactic treatment of asthma. FDA has approved Accretropin injection by Cangene for treatment of pediatric patients who have from an inadequate secretion of normal growth hormone. Merck has announced the approval of Emend for injection for use in preventing acute and delayed nausea and vomiting.
-
product showcase.
The article evaluates several drugs including Cleviprex by the Medicines Co., Navstel Intraocular Irrigating Solution from Alcon Laboratories Inc., and tenofovir by Gilead Sciences Inc.
-
product showcase.
The article evaluates the several medical products including Mircera from Hoffman-La Roche Inc., Zyrtec from McNeil Consumer Healthcare, and Nexavar from Bayer AG.
-
product showcase.
The article evaluates several products including the Pristiq serotin-norepinephrine reuptake inhibitor from Wyeth, the Humira from Abbott Laboratories Inc., and the Nexium from AstraZeneca PLC.
-
product showcase.
The article evaluates several products related to health including Voluven from Fresenius Kabi AG, Thyrogen from Genzyme Corp., and Cialis from Eli Lilly &Co.
-
product showcase.
The article evaluates several medicines including Kogenate FS recombinant antihemophilic factor from Bayer AG, Treanda from Cephalon Inc., and Apidra from Sanofi-Aventis SA.
-
Products to control bleeding.
The article offers information on the first topical thrombin solution used to control bleeding from capillaries and small venules after surgery. The solution, which was approved by the Food and Drug Administration (FDA), is a recombinant form of thrombin that is similar to human thrombin. The product was also approved for patients undergoing liver or vascular surgery. It is manufactured from a genetically modified Chinese hamster ovary cell line that is known to free of infectious agents.
-
productshowcase.
The article evaluates several medical supplies including the ProAir HFA from Teva Pharmaceutical Industries Ltd., Keppra tablet from UCB Inc., and carbidopa/ levodopa orally disintegrating tablets from Mylan Inc.
-
Project Destiny enters its second phase.
The article reports that Project Destiny has completed the first phase of a 10-year program of developing a replicable, scalablen and measurable model for community pharmacy in the U.S. The project aims to identify ways in order for patient and the health care system to benefit from community pharmacy's medication expertise. The project is a joint initiative of APhA, the National Association of Chain DrugStores, and the National Community Pharmacists Association.
-
Proud to be a pharmacist.
The author reflects on his profession as a pharmacist. He shares that he was proud to be a pharmacist, since he and other pharmacists, are creating an exciting new future and making a difference in the lives of patients. The author also stresses the effort of the American Pharmacists Association Foundation for leading the way toward establishing a business model to support pharmacists' medication therapy management (MTM) services to employees and their dependents.
-
PSPC and the voice of the patient.
The article provides information on the Persons United Limiting Substandards and Errors in Health Care (PULSE) founded by Jennifer Dingman in the U.S. PULSE offers support, education, and advocacy for patients. It also serves as the voice of the patient in the Patient Safety and Clinical Pharmacy Services Collaborative (PSPC), reminding health care centers about those lives they will ultimately affect.
-
PSPC announces collaborative faculty members.
The article lists the Patient Safety and Clinical Pharmacy Services Collaborative (PSPC) field faculty members and Health Resources and Services Administration (HRSA) liaisons in the U.S.
-
PSSC at APhA2008.
Information about the 2008 Pharmacy Services Support Center (PSCC) Pharmacy Technical training workshop of the American Pharmacists Association is presented. The title of the event was "The Bright Future of Safety Net Pharmacy" and it focused on patient safety, clinical pharmacy and medication therapy management services as they relate to safety net facilities.
-
PSSC welcomes new senior director.
The article profiles Lisa Scholz as the new senior director of Pharmacy Services Support Center (PSSC) in the U.S. She graduated from the University of Houston and served as the Administrative Director of Pharmacy Operations for the Harris County Hospital District in Houston, Texas. She was responsible for a $120-million budget that included 3 inpatient hospitals, the 12 Ambulatory Health Center Pharmacies that filled 2.9 million prescriptions yearly, among others.
-
Quidel and Roche join forces against flu.
The article reports on the plan of Quidel Corp. and Roche to give physicians a combination "test and treat" package that provides a comprehensive influenza treatment option in the U.S. Under the joint venture, Quidel's QuickVue Influenza A+B test and Roche's Tamiflu oral antiviral medication will be offered to doctors in clinics, hospitals, and other point-of-care settings in select markets of the country.
-
Racial disparities continue in cancer care for older patients.
The article focuses on the study which indicates that black patients with cancer who are older than 65 are less likely to receive recommended treatment than white patients. The study examines more than 143,000 U.S. residents who are 66 to 85 years old and who were treated for colorectal, breast, lung, or prostate cancer between 1992 and 2002. The differences in treatment were not affected by limiting analysis to patients who had physician access before being diagnosed of cancer.
-
Record numbers of pharmacists enlist in U.S. Public Health Service.
The article reports on the number of pharmacists on active duty as of September 9, 2008 in the U.S. The record shows that the Public Health Service (PHS) Pharmacy Category includes 1,000 active officers, representing 16% of the PHS Commissioned Corps, including 350 civil service pharmacists and 13 participants in the Junior Commissioner Officer Student Training and Extern Program. It also indicates that the pharmacy profession is the third largest health care vocation in the corps.
-
References.
References for the articles published in the November 2008 issue of "Appropriate Use of Common OTC Analgesics and Cough and Cold Medications" are presented.
-
Research supports folic acid before and during pregnancy.
The article reports on the research on folic acid, which shows that it is an essential factor in preventing birth defects in the U.S. The preliminary results of the study conducted by Katharine Wenstrom of Vanderbilt University Medical Center indicate that taking folic acid supplements may result in 70% lower risk of premature birth. In addition, a year of folic acid supplementation will reduce the risk of premature birth between 28 and 32 weeks of gestation by 50%.
-
Researchers identify genomic cause of common cold.
The article presents a research conducted by Procter &Gamble Co., University of Calgary, and University of Virginia regarding the genomic cause of human rhinovirus. According to the article, researchers have made a confirmation concerning the immunity symptom's response to the rhinovirus and cites several symptoms including congestrion, runny nose, and sore throat. Inasmuch, the researchers have identified medication targets that could mitigate symptoms.
-
Rising stars of pharmacy shine at APhA-ASP MRM.
Information about the topics discussed at the 2008 American Public Health Association Academy of Student Pharmacists (APhA-ASP) Midyear Regional Meeting (MRM) on October 17-19, 2008 is presented. Topics include the empowerment of student pharmacists. The event also gives emphasis on the wide array of goals which are set by several student pharmacists in the U.S. The meeting was hosted by the University of Pittsburgh, Lake Erie College of Osteopathic Medicine, and Duquesne University.
-
Risks of pen injectors.
The article discusses the risks of pen injectors. It states that patients and nurses have accidentally injected epinephrine into their thumbs when attempting to remove the black cap on an EpiPen. It identifies the causes for these errors including inadequate patient instructions, patients find it difficult to verify whether or not the medication was actually administered, and the various designs of pen injector makes it difficult for health care practitioners to learn how to use them properly.
-
Roche emphasizes preparedness for flu season.
The article evaluates the Tamiflu (oseltamivir) from Roche AG.
-
Role of calcium channel blockers in treatment of hypertension.
Objectives: To describe for pharmacists the basics of hypertension with a specific emphasis on the role of calcium channel blockers in the management of this condition. Data sources: Published literature on hypertension identified via a search of PubMed and pertinent government Web sites. Data synthesis: Hypertension affects more than 70 million Americans. and many patients are unaware of their condition. The pathophysiology, risk factors, and nonpharmacologic and pharmacologic management of hypertension are described in this article. Pharmacists can play a major role in educating patients on hypertension, counseling patients on the importance of lifestyle modifications and drug therapy, and encouraging adherence. Conclusion: Hypertension is a major risk factor for cardiovascular morbidity and mortality. By understanding hypertension and its appropriate management, pharmacists can effectively manage patients, reducing adverse events and improving longterm outcomes.ABSTRACT FROM AUTHORCopyright of Pharmacy Today is the property of American Pharmacists Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.
-
Roles for pharmacy in combatting counterfeit drugs.
Objectives: To describe (1) the international scope of counterfeit drugs, (2) international and U.S. anticounterfeiting initiatives, and (3) the enhanced roles and challenges facing pharmaceutical organizations and individual pharmacists to thwart counterfeit drugs. Data sources: PubMed and Ovid from 1970 to 2008 using the search terms counterfeit drugs, counterfeit pharmaceuticals, and counterfeit medicines, with English as the limiting term. Nonprimary literature sources included the U.S. Food and Drug Administration (FDA) Web site (www.fda.gov) from 1990 to 2008 using the search term counterfeit drugs, presentations from meetings or workshops attended or accessed via the Internet, and Web sites of professional organizations. Additional resources were identified from personal bibliographies collected by the author and bibliographies of gathered articles. Data synthesis: Counterfeit drugs—defined as those containing no active ingredient, an incorrect amount of active ingredients, incorrect ingredient, and/or unapproved labeling and packaging—represent an unquantified problem of international proportions. The existing situation has been facilitated by inconsistent national regulatory oversight, disparate unlinked databases, lack of unified anticounterfeiting actions, and inability to track the distribution of domestically produced or imported drug products between, among, and within nations. In the United States, several important anticounterfeiting initiatives announced by FDA in 2004 have been implemented but the benefits of others, such as electronic tracking of a drug's movement through the U.S. distribution chain to a dispensing pharmacy, will not be realized in the near future. The role of pharmacists as patient educators, prudent purchasers, and detectors of counterfeit drugs can typically be accomplished with minimal added expense or work; however, the impact of electronic tracking on pharmacies' expenses and workflow is unknown. Pharmacists need to be included in efforts to thwart receipt of counterfeit drugs by patients, but this must be accomplished with minimal negative impact on pharmacy practices. Conclusion: Although consistent detection of counterfeit drugs is difficult, pharmacists can take several reasonable measures to lessen the chances they are dispensing counterfeit drugs. However, the increased role of pharmacists is accompanied by several important challenges involving increased expense and altered business practices.ABSTRACT FROM AUTHORCopyright of Pharmacy Today is the property of American Pharmacists Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.
-
Romiplostim: First and only platelet producer approved for chronic ITP.
The article reports on the approval of the romiplostim drug for treating thrombocytopenia in patients with chronic immune thrombocytopenic purpura by the U.S. Food and Drug Administration (FDA). The drug's approval was based on the results of the two studies which found that the drug increases the risk for development of reticulin fiber deposition within the bone marrow and for hematologic malignancies. Meanwhile, FDA has developed a risk evaluation strategy to ensure the safe use of the drug.
-
Safety issues associated with commercially available energy drinks.
Objective: To describe benefits and adverse effects associated with the consumption of energy drinks. Data sources: Searches were conducted using Medline, IPA (International Pharmaceutical Abstracts), EMBASE, and MANTIS; databases such as Natural Medicines Comprehensive Database, Natural Standard, ALTMEDEX, and AltHealthWatch; and Google (range 1980 to September 2007). Search terms included energy drink, Red Bull, caffeine, glucose, ginseng, guarana, taurine, and bitter orange. Data synthesis: Most energy drinks contain natural products such as guarana, ginseng, and taurine. As much as 80 to 300 mg of caffeine and 35 grams of processed sugar per 8-ounce serving are commonly present in energy drinks such as Cocaine, Pimp Juice, Red Bull, and Spike Shooter. No reports were identified of negative effects associated with taurine, ginseng, and guarana used in the amounts found in most energy drinks. Commonly reported adverse effects seen with caffeine in the quantities present in most energy drinks are insomnia, nervousness, headache, and tachycardia. Four documented case reports of caffeine-associated deaths were found, as well as four separate cases of seizures associated with the consumption of energy drinks. Conclusion: The amounts of guarana, taurine, and ginseng found in popular energy drinks are far below the amounts expected to deliver either therapeutic benefits or adverse events. However, caffeine and sugar are present in amounts known to cause a variety of adverse health effects.ABSTRACT FROM AUTHORCopyright of Pharmacy Today is the property of American Pharmacists Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.
-
Safety of plastic chemical in question.
The article cites a report by the U.S. National Toxicology Program concerning bisphenol A (BPA), a chemical widely used in consumer plastic products. The report reveals that BPA is associated with reproductive and development problems in infants and children. It cites the survey which found BPA in the urine of 93% of individuals age six years or older. In response, the Food and Drug Administration has scheduled a hearing to review the report and assess the potential harmful effects of BPA.
-
Safety problems more likely in late-approved drugs.
The article reports on a research which indicates that prescription drugs approved by the U.S. Food and Drug Administration shortly before the congressionally mandated deadline for new applications have a higher frequency of safety issues. It mentions that the study has determined that drugs approved in the 2 months before the Prescription User Fee Act deadline are likely to be withdrawn for safety reasons and carrying a black-box warning.
-
San Francisco bans cigarette sales in pharmacies.
The article reports on the approved legislation by the San Francisco Board of Supervisors in California regarding a ban on cigarette sales in pharmacies. It states that all pharmacies in the city will not be allowed to sell tobacco products. According to Mary Anne Koda-Kimble, dean of the School of Pharmacy, there is no place in a setting that promotes health to sell a product that causes death and disease.
-
Sapropterin: A novel therapy for phenylketonuria.
The article offers information on Sapropterin, a novel therapy for reducing phenylalanine blood levels in patients with phenylketonuria (PKU). It cites that the safety and efficacy of sapropterin have been assessed in various clinical studies of patients with PKU. Moreover, it is noted that sapropterin is only effective in patients with BH<sub>4</sub>- responsive PKU.
-
Say it ain't so!
The article reports on the scandal faced by professional baseball player Jim Bouton when his book "Ball Four" openly explores the widespread use of amphetamines in the U.S. Major League Baseball (MLB) Commissioner Bowie Kuhn has demanded that the allegations of Bouton should be retracted. Meanwhile, it cites that the report released by former Senator George Mitchell has also drawn attention to the problem of businesses that allegedly supply illegal performance enhancing drugs (PEDs).
-
Schwarz recalls Neupro Parkinson's treatment.
The article reports on the product recall made by Schwarz Pharma AG for its Neupro, a treatment for early-stage idiopathic Parkinson's disease in April 2008 in the U.S. The company made the recall which will start and end in April, due to the reports of rotigotine crystals that form in Neupro patches. The treatment will not be available in the country after the date of its recall.
-
Semantics: "A rose by any other name…".
The article discusses various reports published within the issue including the Counseling Corner column, an editorial on managers of pharmacies by John A. Gans, and the introduction to Sherry Butler's practice in the cover story.
-
Sharing liability for a single indivisible event.
The article discusses a pharmacy malpractice case and those who has the liability for the harm done. It states that the Court of Appeals of Georgia ruled that an award granted in favor of a deceased patient's estate was to be shared by both the pharmacy that made a mistake in dispensing a medication to the patient and the hospital at which the patient had been treated for effects of the dispensing error.
-
Silodosin: A selective alpha-1 blocker for BPH.
The article evaluates the Rapaflo silodosin, an alpha-1 adrenergic receptor antagonist for benign prostatic hyperplasia, from Watson Co.
-
Small-town pharmacy in a megastore.
The article focuses on the personalized services offered by Shoppers Food &Pharmacy to its patients in Pasadena, Maryland. The intiative had been spearheaded by the pharmacy's manager, Sherry Butler, who expressed passion in serving her community as a pharmacist. She had also been influential in the implementation of medication therapy management services to patients visiting in the pharmacy. She claimed that the design of their drugstore allows patients to look lastly on pharmacists.
-
Sniffing out dispensing errors involving Zantac and Zyrtec.
The article reports on the mix-up involving Zantac syrup or ranitidine from GlaxoSmithKline and Zyrtec syrup or cetirizine from Pfizer Inc. that caused numerous dispensing errors involving pediatric patients. According to the Institute for Safe Medication Practice, verification process for liquids can often be done by the medication's smell since Zantac has a peppermint scent and Zyretec has a grape scent. Pharmacists need to familiarize the scent and color alone to avoid error recurrences.
-
Sometimes learning has to incubate.
The author reflects on the importance of integrating one's learning into practice and gaining experience with one's chosen career. The author illustrates how she was able to understand the technicality of her profession as pharmacist when she was able to integrate the principles of being a mother. She stresses on the need for pharmacists to adopt to the changes of the industry, specifically in drug labeling revisions, changes in disease guidelines as well as the introduction of new drugs.
-
Speaking out.
Several letters to the editor are presented in response to the article "Washington Insider," in the October 2007 issue.
-
Speaking out.
A letter to the editor is presented in response to the article on certification of pharmacy technicians published in April 2008 issue.
-
Speaking out.
A letter to the editor is presented in response to the article "No right to sue for switch of emergency contraceptive to OTC status," in the May 2008 issue.
-
Speaking out.
A letter to the editor about influenza vaccination is presented.
-
Speaking out.
A letter to the article is presented in response to the articles in previous issues including "Semantics," by Michael Posey and "Proud to be a pharmacist," by John Gans in the January 2008 issue.
-
Speaking out.
A letter to the editor is presented in response to the article "OTC product: OV-Watch Fertility Predictor" in the August 2008 issue.
-
Speaking out.
A personal narrative is presented which explores the author's experience in tending the Ukrainian patient with myocardial infarction.
-
Speaking out.
A letter to the editor is presented which is about the clinical and management roles for pharmacy technicians in the U.S. in the November 2007 issue.
-
Stebbins integrates MTM Core Elements into office-based practice.
The article profiles pharmacy professor Marilyn Stebbins in Sacramento, California. Stebbins was responsible for the integration of medication therapy management (MTM) as a clinical office-based practice that carries out all the clinical, humanistic and economic outcomes of pharmacotherapy. She was also instrumental in creating the Pharmacists Review to Increase Cost-Effectiveness (PRICE) clinic that enforces physicians to prescribe generic medications.
-
Stimulant treatment for ADHD doesn't lead to substance abuse.
The article reports on the results of the study conducted by physician Joseph Biederman and colleagues at Massachusetts General Hospital in Massachusetts. According to the researchers, using stimulant drugs in treating children with attention deficit hyperactivity disorder (ADHD) does not increase future risk of substance abuse. Biederman said that there is no evidence that prior treatment with stimulants was associated with increased or decreased risk for subsequent drug or alcohol abuse.
-
Stormy weather, specialty care.
The article offers a look on the work of pharmacist Salvador Scaccia after Hurricane Katrina hit in New Orleans, Louisiana. About a month after the hurricane, he was offered a job in Texas at specialty pharmacy that offered training in eight specialty care fields like, dermatology, rheumatology, and oncology. In May 2008, he opened his new pharmacy named Total Life Care Pharmacy. He decided to focus on four main specialties such as infectious diseases, oncology, and autoimmune disorders.
-
Strategies to eliminate race-based disparities in pain management.
The article announces that pharmacists can use various strategies that can eliminate race-based disparities in pain management in the U.S. It suggests that using objective criteria can help lessen uncertainty in pain management and can therefore lessen the effects of negative stereotypes. It recommends that pharmacists should be mindful to ensure that stereotypes do not affect their interpretation of the legitimacy of any patient's pain complaint or prescription.
-
Study shows higher allergic reaction rate for Gardasil.
The article cites a study which reveals that Gardasil quadrivalent vaccine have significantly higher allergic reaction rate than other vaccines given to pediatric patients. The study found allergic reaction rate of 2.6% of anaphylaxis per 100,000 doses after reviewing records from a program that administered 270,000 individual doses of the 3-dose immunization. It also reveals that the incidence of human papilloma virus-related reaction is 5 to 20 times greater than other common vaccinations.
-
Study: Vitamin B doesn't improve Alzheimer's symptoms.
The article reports on a study which reveals that no evidence of the hypothesized action of vitamin B on the symptoms of Alzheimer's disease. More than 400 patients with mild to moderate Alzheimer's participated in the study, which analyzed the effects of high-dose folate, vitamin B6, and vitamin B12 supplementation. While the trial identify the homocysteine-lowering effect, there was no improvement in the primary cognitive measure, rate of change of Alzheimer's Disease Assessment Scale score.
-
Successful contracting with payers.
The article reports on the medication therapy management (MTM) and elaborates the key steps to establish a contractual agreement with the payer. It cites that MTM is characterized as a unique group of services that amplifies several therapeutic results in every patient and its services are independent but it can be acquired when needed. Among the steps related to contractual agreement include the completion of a strengths-weaknesses-opportunities-threats analysis.
-
Sunitinib may raise blood pressure; still good treatment, researchers say.
The article focuses on the research which indicates that sunitinib, a receptor tyrosine kinase inhibitor used to treat kidney and stomach cancer causes high blood pressure. It is reported that there is an increase in blood pressure of 15 percent to 25 percent in patients with renal carcinoma. It is further recommended that health providers should closely monitor the blood pressure of patients who are taking sunitinib to manage hypertension.
-
Supplement use driven by chronic illnesses.
The article reports on a research which indicates that 82% of patients who suffer from chronic illness use two or more dietary supplements than those without chronic diseases. It relates that the investigation by Melissa Farmer Miller and colleagues on cancer survivor patients and patients without cancer determined that supplement use by cancer survivors is directed at dealing with, or preventing the exacerbation of comorbid conditions.
-
Take counseling to the next level with patient profiles.
The article offers tips which helps to maximize the benefits of invaluable information during counseling session. They include starting the counseling sessions by verifying the name of the patient and its date of birth. The allergy of the patient should be also discussed during the counseling sessions. Moreover, it is noted that the profiles of the patient is very important because it will help to determine if medical conditions are being treated according to national practice guidelines.
-
Task force submits BPS petition on ambulatory care pharmacist specialty.
The article reports on the collaboration of the American Public Health Association (APhA) with the American College of Clinical Pharmacy (ACCP) and American Society of Health-System Pharmacists (ASHP) to make a petition for the recognition of ambulatory care pharmacy practice in the U.S. It mentions that these organizations have formed a task force to submit a petition for recognition to the Board of Pharmaceutical Specialties (BPS). The essence of ambulatory care pharmacy practice is mentioned.
-
Teeth-whitening products.
The article offers information on different efficacy and side effect of various teeth-whitening products in the U.S. It cites that these teeth-whitening products includes tray whitening, whitening strips, pain-on teeth whitening, and whitening toothpastes. It reveals the most adverse effects of tray whitening are tooth sensitivity and gingival or mucosal irritation. Moreover, it is noted that the abrasive effects of teeth-whitening toothpaste can damage the teeth and leads to cold sensitivity.
-
Tetrabenazine for Huntington's chorea.
The article reports on the approval of tetrabenazine drug for treating chorea associated with Huntington's disease by the U.S. Food and Drug Administration (FDA). It cites a study which reveals that the drug can increase the risk of depression as well as suicidal thoughts and behavior in patients with Huntington's disease. In addition, it can cause worsening in mood, cognition, functional capacity, and has been associated with adverse reactions such as akathisia and agitation symptoms.
-
Texas researcher helps drug companies go green.
The article reports on the method identified by Jason McConville, Assistant Professor of Pharmaceutics at the University of Texas in Austin, for environmentally friendly manufacturing. The method, based on the organic solvent ethyl lactate, can act as a binding agent in the production and processes of pharmaceuticals. McConville reveals that ethyl lactate's biodegradability and solubility profile make it an ideal solution for ecologically conscious pharmaceutical companies.
-
The counseling flowchart: Order concepts logically.
The article offers tips regarding counseling session between a pharmacist and patient. It states that the session should include a discussion to gather information and identify potential problems. It notes the importance of establish a rapport with the patient. Another is to provide key information such as mentioning the medication name and indication and describing medication administration issues. An example of a well-organized consultation is presented.
-
The greening of APhA.
The author reflects on the greening mission of American Pharmacists Association (APha). He reveals that the goal of APhA is to protect the environment like saving the trees and fishes. He further expresses that APhA has reassessed its various activities to identify ways that can be a better public citizen when it comes to the environment.
-
The increasing menace of community-acquired MRSA.
The article discusses various strategies in preventing and treating community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection. According to the author, the MRSA has been considered the major public health problem in the U.S. that needs to be addressed. Among the suggested prevention strategies include avoiding contact to patients with such illness, practicing of proper hygiene as well as educating patients and caregivers about proper wound management.
-
The One Minute Counselor.
The article offers tips and medication for the treatment of Parkinson's disease (PD) in the U.S. There exists many medications for the treatment of PD but if these are not properly administered, it has it own adverse effects including selective monoamine oxidase (MAO)-B inhibitors, selegiline and rasagiline. It is advised that pharmacists and their patients should be aware of the potential dietary concerns and interactions between MAO-B inhibitors and other medications.
-
Thiazolidinediones may help prevent psoriasis.
The article reports on a research conducted by Christoph R. Meier and colleagues which found that thiazolidinediones (TZD) may prevent psoriasis. It relates that the researchers have identified that regular use of TZDs yielded an adjusted ratio for psoriasis of 0.33 as compared with no use of the drugs. It notes that although the findings provide further evidence on TZDs use on psoriasis, the authors of the study cautioned that the findings were based only on small number of exposed patients.
-
Toolkit helps you promote safe medication use.
The article reports on the team up between APhA foundation and the Institute for Safe Medication Practices (ISMP) in the U.S. The team up aims to create toolkit pharmacists that can be used when speaking about proper medication use in a community. The toolkit will include a brochure on the growing problem of unintentional medication misuse, an ISMP Call to Action White Paper, and a CD that contains PowerPoint slides, speaker notes and health literacy resources.
-
Training tomorrow's leaders.
The article offers information on the executive residency program established by the Knowlton Foundation that seeks to groom the next generation leaders in the pharmacy profession. It states that the aim of the program are to train people for leadership positions within the profession and in national, regional, state and local professional pharmacy or other health-related organizations.
-
Treating the whole patient.
An interview with pharmacists Maya Thompson, Lisa Tonrey and Bradley Bishop are presented. According to Thompson, she will not only focus on the chronic diseases like diabetes, but also on the patient. Tonrey asserts that addressing specific community needs are very important even though they are on national program.
-
Two insulin dosing algorithms effective for patients with type 2 diabetes.
The article reports on a study regarding the efficiency of both a simplified algorithm and carbohydrate counting for patients with type 2 diabetes. It reveals that 73% of patients who followed the simplified algorithm and 69% of patients who used carbohydrate counting achieved the American Diabetes Association's recommended blood glucose target.
-
UCSF School of Pharmacy names Associate Dean for Diversity.
The article announces that Sharon Youmans has been appointed as Associate Professor of Clinical Pharmacy of the University of California, San Francisco (UCSF) School of Pharmacy.
-
UNDER CONSTRUCTION.
A photograph of the American Pharmaceutical Association (APhA) headquarters building on the National Mall in Washington D.C. which is under construction is presented.
-
Update from ADA 2008.
The article offers information on the 2008 American Diabetes Association (ADA) 68th Annual Scientific Sessions which showcased research and treatment recommendations for managing patients with diabetes. Topics include the development of date regarding the effects of aggressive glycemic control, adherence to practice guidelines, and a review of novel agents.
-
Update on construction of APhA headquarters facility.
The article offers updates related to the construction of the headquarters facility of the APhA Foundation on the National Mall in Washington D.C. The construction of the facility has been completed in June 2008. Precast concrete facades were successfully mounted to the structure as well as the addition of the facades to the west side of the building.
-
Updated pneumococcal vaccination guidelines regarding asthma, smokers.
The article reports updates announced by the Centers for Disease Control (CDC) Advisory Committee on Immunization Practices (ACIP) concerning pneumococcal vaccination guidelines for asthmatic smokers. Study shows that asthmatic smokers are more likely to experience an increased risk of pneumococcal disease. It also cites that ACIP suggested the use of Pneumovax or pneumococcal polysaccharide vaccine as medication for the asthmatic smokers.
-
Use feedback to verify patient understanding.
The article reports on the significance of using feedbacks to verify patient understanding of information presented throughout the counseling session. It shows the use of feedback helps ensure that the information provided to patient and the patient's interpretation of the information are the same. It suggests that feedback should be obtained from patients throughout the counseling session to ensure that patients have understood the information presented and they follow the recommendations.
-
UVA is important too: Stars proposed for sunscreen products.
The article reports on the plan of the U.S. drug manufacturers to develop sunscreen products for ultraviolet B (UVB) rays. Under the new Food and Drug Administration (FDA) regulations, manufacturers are required to perform new nonclinical and clinical tests to assess the effectiveness of the products in minimizing the effects sun exposure. Furthermore, the FDA has also required manufacturers to integrate new labeling standards to inform consumers about the protective capacity of the products.
-
Vitamin C may indicate reduced stroke risk.
The article reports on the medical study on Vitamin C, which shows that it is an essential factor in reducing the risk of certain stroke in Great Britain. Researchers at the University of Cambridge determined that patients with Vitamin C levels in the top quartile had a 42% lower risk of stroke than those with vitamin C concentrations. These findings were independent of age, sex and smoking history. The researchers concluded that vitamin C may represent a biological marker of lifestyle.
-
Wayne State immunization drive reaches more than 1,100 patients.
The article provides information on the influenza immunization drive administered by the student pharmacists of the Wayne State University (WSU) in Detroit, Michigan. According to the article, the student pharmacists have administered more than 1,100 faculty and staff members of the same university for over six days at the university's influenza clinic. In addition, the immunization drive was participated by 60 certified student immunizers, faculty members, and preceptors.
-
West Virginia legislature authorizes pharmacist immunization.
The article reports on the House Bill 3056 of West Virginia Legislature that authorizes pharmacist immunization on March 7, 2008 in West Virginia. The bill would allow pharmacists to administer hepatitis A, hepatitis B, influenza, and other conditions to persons older 18 years of age after completing education and training approved by the Board of Pharmacy. The bill led the state to become the 48th state to permit pharmacists to administer immunizations.
-
What's in a name? Preventing errors linked to name confusion.
The article offers several steps to be considered to avoid errors related to product name confusion in the U.S. Pharmacists are advised clearly specify the drug name, dosage form, strength, complete direction and indication in their prescriptions. Other steps include making physical changes in pharmacy and using at least two independent checks in the dispensing process.
-
Who loves the sun? Maybe more should.
The article focuses on the study which indicates that the health benefits of modest sun exposure outweigh the risks of having skin cancer. According to the study, sunlight promotes production of vitamin D in the body, which may help stave off cancers, rickets, osteoporosis, and diabetes. The researchers determined that in the same amount of time spent under the sun, Australians residing near the equator produced 3.4 and 4.8 times as much vitamin D as residents in Great Britain and Scandinavia.
-
Working with caregivers.
The article discusses the work of a caregiver. It cites that caregivers can offer support to patients in their home and everyday life. A caregiver's continuous support and positive reinforcement can remind patients of the plan to improve their health and encourage them to follow that plan. The presence of a caregiver can improve medication adherence. Moreover, increased adherence to medication regimens may lead to decreased hospitalization rates in patients with chronic medical conditions.
-
Working with self-insured employers.
The article offers tips in developing effective programs for self-insured employers in providing direct patient care and receiving reimbursement for patient-centered services. It includes finding a self-insured employer group willing to collaborate and identifying the key decision maker. Also, it provides tips on how to develop an employer-based business plan including designating a pharmacist with excellent interpersonal skills, developing marketing materials, and providing reports.
-
Workshops at APhA2008 offer ways to partner with safety net providers.
The article announces that the American Pharmacists Association (APhA) offers workshops that focus on building successful partnerships to serve patients better in the U.S. Evidently, the Health Resources and Services Administration (HRSA) and the Pharmacy Services Support Center (PSSC) sought to collaborate with pharmacists in creating a continuing education session that aims to develop medical care services.
-
Wrapping it all up.
The article reviews the book "Stop--Learn--Go: Tips for Talking With Your Pharmacist to Learn How to Use Medicines Safely."
-
You can help with Medicare's annual open enrollment period.
The article reviews the Medicare Prescription Drug Plan Finder software.
-
You say 'tomato,' I say 'tomahto': Speaking patients' language.
The article discusses the importance of health literacy in improving the communication between pharmacists and patients in the U.S. Health literacy is essential to help patients understand verbal instructions or health information like brochures or prescription levels. Pharmacists are advice to use plain and nonmedical language, provide information in a patient's primary language, and read drug information resources.
-
Your New Year's resolution: Expand patient-focused care.
The article offers tips on how pharmacists may improve a patient's overall medication use and health care through medication therapy management (MTM).
Have a comment about this page?
Please, contact us. If this is a correction, your suggested change will be reviewed by our editorial staff.